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Enterobacter sakazakii has been associated with powdered infant formula
outbreaks which caused high mortality rate illnesses in infants in recent years.
Current research was mainly focused on searching for natural antimicrobial agents
which may be incorporated into baby foods to control this emerging pathogen.
Yogurt and muscadine products were used in this study.
The antimicrobial effects of yogurt were evaluated on agar plates and in a
simulated gastrointestinal model.

In the agar spot tests, diluted yogurt sample

containing lactic acid bacteria at 106 CFU/mL was antagonistic toward E. sakazakii.

However, the antimicrobial effect of yogurt on E. sakazakii in the simulated GI model
was not noted.

Certain numbers of tested E. sakazakii and lactic acid bacteria in

yogurt were able to survive the acidic gastric condition and recovered in the intestinal
model.
By measuring the viable E. sakazakii cells in liquid cultures, the strong
antimicrobial activities of muscadine juices and muscadine seed extracts were
demonstrated.

Within two hours, all inoculated E. sakazakii at 106 CFU/mL were

decreased to non-detectable level.

Juice and seed extract from dark-skinned

muscadine demonstrated stronger antimicrobial activities than those form
white-skinned muscadine.
were also analyzed.

The characteristics of muscadine juices and seed extracts

The high phenolics and organic acid contents, such as ellagic,

gallic, tannic, and tartaric acids in muscadine were correlated to the inhibitory effect
observed.
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CHAPTER I
INTRODUCTION

The outbreaks of foodborne illness associated with Enterobacter sakazakii and
their high mortality rates have attracted much attention in recent years (Bowen and
Braden 2006; Mullane and others 2007). Enterobacter sakazakii has been reported to
grow rapidly in infant formula once it was reconstituted and may remain viable at
refrigerated temperature (Bowen and Braden 2006).

Although the mechanism of

pathogenesis still remains unclear (Drudy and others 2006; Skovgaard 2007), E.
sakazakii has been suggested to be sensitive to acidified food product (Kim and
Beuchat 2005; Shaker and others 2008).
Considering the potential inhibition effect and the convenience to deliver to
infants, two acidic food products, yogurt and muscadine juices, were selected for
investigating their antimicrobial effect against E. sakazakii. Yogurt, one of the most
popular carriers of lactic acid bacteria, is known to possess antagonistic effect against
various pathogens (Shornikova and others 1997; Gagnon and others 2004). High
1

phenolic contents of muscadines and their health benefits, such as antioxidant activities,
anticancer properties, and anti-inflammatory, have been reported (Pastrana-Bonilla and
others 2003; Greenspan and others 2005; Mertens-Talcott and others 2006).

However,

few studies have been conducted to evaluate the antimicrobial effect of muscadines.
This research may be the first study to investigate the antimicrobial activity of
muscadine juices.
The extracts from muscadine seeds, which are considered a by-product in juice
and winery processing, were also used in this study. Grape seeds have been reported
to have the antimicrobial effect against several human pathogens (Jayaprakasha and
others 2003), and have been used as natural preservatives in ready-to-eat products
(Theivendran and others 2006).

However, no studies have been reported on the

inhibitory effect of muscadine seed on E. sakazakii.
The objectives of this study were to:
1. Evaluate the antagonistic effect of yogurt against E. sakazakii in the agar spot test.
2. Determine the viability of lactic acid bacteria in yogurt and E. sakazakii in a
simulated gastrointestinal (GI) system.
3. Evaluate the antagonistic effect of yogurt lactic acid bacteria toward E. sakazakii in

2

the simulated GI system.
4. Evaluate the antimicrobial effect of muscadine juices subjected to different
treatments on inhibition of E. sakazakii.
5. Evaluate the inhibitory effect of hot and cold muscadine seed extracts against E.
sakazakii.
6. Correlate the antimicrobial effect of muscadine seed extracts with the concentration
of major phenolics and organic compounds in the seed extracts.

3

CHAPTER II
LITERATURE REVIEW

Enterobacter sakazakii
Enterobacter sakazakii is a member of the family Enterobacteriaceae, and genus
Cronobacter.

The

Enterobacter

spp.,

a

group

of

motile,

peritrichous,

non-sporeforming, facultatively anaerobic, Gram-negative straight rods, is able to
ferment glucose with production of acids and gases, and gives a positive
Voges-Proskauer reaction.

It is biochemically similar to E. cloacae, and forms yellow

colonies on nutrient agar or tryptic soy agar; therefore, E. sakazakii was previously
called ‘yellow-pigmented E. cloacae’ (Richard 1984).

Based on the differences

between the two species in DNA relatedness, biochemical reactions, pigment
production, and antibiotic susceptibility, E. sakazakii was formally listed as a new
species and named in honor of the Japanese microbiologist Riichi Sakazaki (Farmer
and others 1980).

4

Figure 2.1 shows the remarkably increasing number of publications in regards to
E. sakazakii, from 1989 to 2007. E. sakazakii has been receiving attention in recent
years as an emerging, opportunistic pathogen associated with life threatening
meningitis, necrotizing enterocolitis and sepsis in infants (Iversen and Forsythe 2003).
These E. sakazakii related diseases are rare, but high mortality rates of meningitis
(40-80%) and enterocolitis (10-55%) have been reported (Nazarowec-White and
Farber 1997a; Lai 2001).

Among 111 reported cases of E. sakazakii infection

worldwide from 1958 to 2005, at least 26 deaths are reported in infants and children
(Mullane and others 2007).

Additionally, cases involving E. sakazakii related

bacteremia and osteomyelitis in postsurgical adults and immunocompromised elders
have also been reported (Lai 2001; Corti and others 2007; Ray and others 2007; See
and others 2007).

Although E. sakazakii affects all age groups, premature and low

birth weight (under 2,500 g) neonates (less than 28 days) are found at the highest risk
(Mullane and others 2007).

Furthermore, irreversible neurological sequela and

retarded neural development have been found in meningitis survivors (Muytjens and
others 1983; Willis and Robinson 1988).

5

In 1980, Farmer and others reported that antibiotic resistance was uncommon in E.
sakazakii, and only one strain out of over one hundred tested strains was multiple
resistance. Enterobacter sakazakii was naturally sensitive or intermediate to some
antibiotics,

including

(acylureidopeicillins,

tetracyclines,
ticarcillin,

aminoglycosides,

and

chloramphenicol, and nitrofurantoin.

ampicillin),

numerous
quinolones,

β-lactams
antifolates,

It had natural resistance to benzylpenicillin,

oxacillin, lincosamides, streptogramins, glycopeptidesm, rifampicin, and fusidic acid
(Stock and Wiedemann 2002).

Ampicillin in combination with gentamicin or

chloramphenicol was traditionally used to treat E. sakazakii infections (Willis and
Robinson 1988; Lai 2001).

However, Lai (2001) reported that all E. sakazakii

isolates were resistant to ampicillin, cefazolin and penicillin, and proposed the use of
carbapenems, the third-generation cephalosporins with an aminoglycoside or
trimethoprim-sulfamethoxazole.

Owing to the acquisition of transposable elements

and the production of β-lactamases, Enterobacter species are able to inactivate several
β-lactam containing antibiotics (Girlich and others 2001; Iversen and Forsythe 2003).
Plasmid-mediated quinolone resistance gene (Qnr-A) in E. sakazakii was also reported
to cause nosocomial spread (Poirel and others 2007).
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Enterobacter sakazakii in food and powdered infant formula
Enterobacter sakazakii is distributed widely in the environment, including water,
soil, households, food factories producing powdered milk, chocolate, cereals, potato
flour and pasta (Kandhai and others 2004; Friedemann 2007).

It has also been

isolated from a variety of food products, such as cheese, dried fish products, meat,
vegetables, grains, herbs and spices (Kim and Beuchat 2005; Richards and others 2005;
Chaves-López and others 2006; Kim and others 2008a).

In addition, some

researchers believed that rats and flies may be the possible vectors of this bacterium
(Gakuya and others 2001; Mramba and others 2007).
Powdered infant formula is designed as a breast milk substitute with formulated
nutritional profile.

However, many foodborne outbreaks in children have been

epidemiologically associated with the ingestion of contaminated powdered infant
formula (Biering and others 1989; CDC 2002).

During 2005 to 2007, there were 14

out of 49 recalls of infant formula due to E. sakazakii contamination worldwide (ICDC
2008).

Environmental contamination of infant formula during processing is likely to

be the source of E. sakazakii (Kandhai and others 2004). In the first survey of the
incidence of E. sakazakii in 141 infant formulae from 35 countries, E. sakazakii was
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found at level ranging from 0.36 to 66 CFU/100g in 20 infant formulae from 13
countries (Muytjens and others 1988). Nazarowec-White and Farber (1997) reported
that the levels of E. sakazakii were 0.36 CFU/100g in 3 positive samples out of 120
cans of infant formulae from five Canadian companies. Generally, E. sakazakii is
found at low concentration in most positive powdered infant formula samples.
However, this bacterium can multiply rapidly in reconstituted powdered infant formula.
It takes only 45 min for E. sakazakii to double in reconstituted formula at room
temperature (Forsythe 2005). Thus, prolonged storage of reconstituted infant formula
at room temperature or in a bottle warmer might increase the possibility of E. sakazakii
infection of infants (Mullane and others 2006).
Powdered infant formulae have a low water activity (aw) of about 0.2.

Breeuwer

and others (2003) reported that E. sakazakii in stationary phases were relatively more
resistant to dry stress in comparison to Escherichia coli, Salmonella, and other
members of the Enterobacteriaceae family, which are common contaminates found in
powdered milk.

Following incubation at 25˚C, exponential phase E. sakazakii

decreased by seven log unit in ten days, while stationary phase cells decreased by 1 to
1.5 log units in 46 days.

They added that the dry resistance is likely linked to the
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trehalose accumulated in the cells. Gurtler and Beuchat (2007) and Lin and Beuchat
(2007) studied the parameters affecting E. sakazakii survival.

They found that E.

sakazakii strains could survive in powdered infant formula and infant cereal (aw range
from 0.25 to 0.86) for up to 12 months at all tested temperatures (4 to 30˚C), even with
lower initial inoculation (less than 1 log CFU/g).

Although increases in the aw and

temperature cause an increase in the rate of death, the survival of E. sakazakii was not
influenced by the composition of powdered infant formula or infant cereal (Gurtler and
Beuchat 2007; Lin and Beuchat 2007).

Some strains of E. sakazakii were reported to

have the ability to survive in dehydrated powdered infant formula for two years
(Edelson-Mammel and others 2005; Caubilla-Barron and Forsythe 2007).
Enterobacter sakazakii is one of the most thermal resistant microorganisms
among Enterobacteriaceae members found in dairy products (Nazarowec-White and
Farber 1997c).

Iversen and others (2004) reported the D value of E. sakazakii at

58˚C was 2.4 min, compared with 4.2 min reported by Nazarowec-White and Farber
(1997).

The overall z value (5.7-5.8˚C) was similar in both studies.

Thus, the

predicted D value of E. sakazakii in infant formula at 71.2˚C was 0.7 s. These data
would indicate that the high-temperature short-time pasteurization process (71.7˚C for
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15 s) is effective for the inactivation of E. sakazakii in milk (Iversen and others 2004).
However, diversity in thermal tolerance among the strains of E. sakazakii was found.
The D values of 12 strains of E. sakazakii at 58˚C ranged from 30.5 to 591.9 s
(Edelson-Mammel and Buchanan 2004).

Thus, some high-temperature tolerant

strains of E. sakazakii may exist.
Several newer processing technologies, such as irradiation, ultra-high pressure
and pulsed electric fields, have been tested for the reduction of E. sakazakii in infant
formula.

When exposed to Gamma irradiation, E. sakazakii D10-values ranged from

0.21 to 0.29 kGy and 0.76 to 1.71 kGy in broth and dehydrated powdered infant
formula, respectively (Lee and others 2006; Osaili and others 2007). When exposed
to high-pressure processing (600 MPa for 1 min), E. sakazakii was reduced by 3 to
6.84 log in inoculated reconstituted powder infant formula (González and others 2006).
After exposure to pulsed electric fields for 360μs at 40 kV/cm, E. sakazakii in
reconstituted powder infant formula was reduced 1.2 log CFU/mL (Pina Pérez and
others 2007).
Since E. sakazakii is possibly introduced to product after pasteurization process
by adding other heat sensitive ingredients and/or contamination from nonsterile
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equipment, the growth parameters of E. sakazakii in reconstituted infant formula were
also investigated.

The estimated optimal growth temperature was 39.4˚C, while E.

sakazakii was found able to grow in reconstituted infant formula at temperatures
between 5.5 to 47˚C.

The average generation times were 40 min at 23˚C and 4.98 h

at 10˚C (Nazarowec-White and Farber 1997b; Kandhai and others 2006).

Therefore,

Gurtler and Beuchat (2007) suggested that portions of reconstituted infant formula
should be stored at or below 4˚C, and no longer than four hours.
Acidification has been found to lower the concentration of E. sakazakii (Joosten
and Lardeau 2004; Friedemann 2007; Lin and Beuchat 2007). Josten and Lardeau
(2004) proposed that acidification, either through fermentation or by direct addition of
lactic acid, could prevent the rapid microbial growth in infant formula. Infant rice
cereal reconstituted with apple juice at pH 4.29 did not support the growth of
inoculated E. sakazakii up to 9.3 CFU/mL, while this bacteria grew rapidly in infant
rice cereal reconstituted with water , milk, or infant formula (Richards and others
2005).
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Pathogenicity and virulence factors
The mechanism of pathogenesis of E. sakazakii still remains unknown (Drudy and
others 2006; Skovgaard 2007). Generally, the gastrointestinal tract is a suggested
portal of entry among patients with Enterobacter spp. bacteremia, and meningitis is
believed to occur by translocation of invasive bacteria (Iversen and Forsythe 2003;
Pagotto and others 2003).

The adherence and invasion capacity of E. sakazakii to

intestinal epithelial cells and the brain microvascular endothelial cells was
demonstrated (Mange and others 2006; Mohan Nair and Venkitanarayanan 2007;
Townsend and others 2007b; Kim and others 2008a).

The more permeable intestinal

tracts of premature infants and immunocompromised individuals might make them
highly susceptible to E. sakazakii (Lenati and others 2008). Furthermore, the less
acidic stomach of newborns and the buffering capacity provided by ingested milk also
contribute to survival and infection of E. sakazakii in infants (Forsythe 2005; Lenati
and others 2008).
Contaminated feeding utensils, such as blenders, spoons, and bottles, used for the
preparation of infant feed have been linked to E. sakazakii infection (Bar-Oz and
others 2001).

Recent studies found that some E. sakazakii strains have the ability to
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form biofilms, enabling the organism to attach to common food preparation surfaces,
including silicon, latex, polycarbonate, stainless steel, glass, and polyvinyl chloride
(Iversen and others 2004; Lehner and others 2005; Kim and others 2006; Oh and others
2007).

Inversen and others (2004) reported that higher populations of E. sakazakii

attached to silicon, latex and polycarbonate than to stainless steel. Kim and others
(2006) found the attachment strength of E. sakazakii was stronger when growing at
25˚C than at 12˚C.

Biofilms may also provide protection for bacteria from

environmental stresses, such as UV light, osmotic stress, heat, starvation, acids,
detergents, antibiotics, and bacteriophages (Iversen and others 2004; Lehner and others
2005).
Up until now, there was no evidence for a minimal infectious dose of E. sakazakii
in humans.

It was estimated at 1,000 CFU/ml based on the infectious dose of E. coli

O157 and Listeria monocytogenes 4b (Iversen and Forsythe 2003).

In vitro studies in

suckling mice showed that the lethal level of tested strains was 1 X108 CFU (Pagotto
and others 2003).

They also proposed that the presence of enterotoxin might be the

pathogenesis factor of E. sakazakii.

Besides, recent research indicated that

lipopolysaccharides, a heat stable bacterial endotoxin, may be present in powdered
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infant formula.

Upon ingestion, the endotoxin may contribute to failure of neonatal

intestine integrity, and therefore increase in the bacterial translocation from the gut
(Townsend and others 2007a).

However, these toxins have not been identified yet.

Health benefits of yogurt and lactic acid bacteria
Yogurt is a semisolid fermented dairy product derived by the activity of a
symbiotic blend of lactic acid bacteria (LAB).

Although milk of various mammals is

used for making yogurt in the world, cow’s milk is the most common one used in
yogurt

manufacturing.

Streptococcus

salavarius

subsp.

thermophilus

and

Lactobacillus delburechii subsp. bulgaricus are the most common starter cultures.
These yogurt starter cultures increase the acidity through production of organic acids,
mainly lactic acid, during yogurt fermentation, and thus form a coagulum as well as
achieve preservation, the original function of fermented foods (Chandan and Shahani
1993).
In addition to yogurt starter cultures, probiotics are often added to yogurts
nowadays.

Probiotics have been defined by the Food and Agriculture Organization of

the United Nations (FAO/WHO) and the World Health Organization (WHO) as ‘live
microorganisms which when administered in adequate amounts confer a health benefit
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on the host’ (FAO/WHO 2002).

Among probiotic cultures, Lactobacillus acidophilus,

L. casei and Bifidobacterium spp. are often added to yogurt products (Shah 2001).
In the early twentieth century, the Noble Prize laureate biologist, Élie Metchnikoff
first suggested that the long healthy life of Bulgarians may be attributed to the
consumption of fermented milk products, in which fermenting bacilli may inhibit toxic
microbial activities in the gastrointestinal tract (Holzapfel and others 1998; Hove and
others 1999).

Many studies since then have discussed more beneficial effects of

fermented milk products and lactic acid bacteria, including enhancing the
bioavailability of nutrients, enhancing the immune system, reducing symptoms of
lactose intolerance and reducing risk of certain cancers, attributed to LAB and their
fermented products (Parvez and others 2006).

Calcium and bone health
Health benefits of yogurt are mainly attributed to its high nutrition value and to
the presence of LAB.

The nutrient composition of yogurt is based on the milk it is

made from.

Milk and its products are rich in protein, calcium, phosphorus, and

vitamin B.

In the latest food guide pyramid- MyPyramid, two cups (eight fluid

ounces) of milk, yogurt and/or other milk products were suggested to meet the daily
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calcium requirement, which is vital for bone health (USDA 2005).

Calcium in milk

and yogurt have been considered as valuable sources due to the high content and its
bioavailable form, which is available for absorption and used by human body
(McKinley 2005).

Calcium must be ionized and in solution to be absorbed.

In milk,

calcium complexes to lactate, phosphopeptides, and caseins, which are the forms easily
to be digested and uptake by human gastrointestinal tract (Bronner and Pansu 1999;
Naidu and others 1999). Bronner and Pansu (1999) also reported that the low pH of
yogurt may ionize calcium and thus facilitate calcium absorption.

A study in 1987

showed greater bone mineralization on yogurt-fed rats compared to the ones fed with
calcium carbonate (Adolfsson and others 2004). Particularly for lacto-vegetarians
and lactose intolerance individuals, yogurt are great sources of calcium (Smith and
others 1985; Weaver and Plawecki 1994).

Alleviation of lactose intolerance symptoms
Lactose, the main carbohydrate in milk, is a disaccharide composed of glucose
and galactose.

It can be digested by lactase (β-galactosidase) and subsequently

absorbed in the small intestine.

However, approximately two thirds of the world adult

population loses the intestinal lactase activity gradually after weaning (Vesa and others
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2000).

The intestinal lactase deficiency leads to the inability to digest lactose,

described as lactose maldigestion, malabsorption or lactose intolerance.

When the

undigested lactose enters the large intestine, it can be fermented by the colonic
microflora, causing various degrees of discomfort symptoms, such as flatulence,
diarrhea and abdominal cramping (Vesa and others 2000; Adam and others 2004).
Many lactase-deficient individuals were reported better able to tolerate fermented dairy
products than fresh milk (Savaiano and others 1984; Hertzler and Clancy 2003).
Probiotic cultures, such as L. acidophilus and B. longum, were also reported to aid
lactose digestion in humans when incorporated into unfermented milk (Kim and
Gilliland 1983; Jiang and others 1996).

Both the reduction of lactose during

fermentation and the presence of microbial β-galactosidase released by LAB in the
gastrointestinal transit are responsible for the improved ability to tolerate lactose
(McDonough and others 1987; Hughes and Hoover 1991; Rolfe 2000).

Immune system modulation
The immune system is a complex protection barrier in the body. There are two
immune mechanisms in healthy humans.

The specific immunity is an

antigen-specific immune response and is enhanced by repeated exposure.
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The

nonspecific immunity consists of physical barriers, e.g. mucous membranes and
phagocytic cells (Meydani and Ha 2000).

Stimulation of both specific and

nonspecific immunity by yogurt and probiotics was reported in the literature. The
leukocyte phagocytic activity of human blood cells was enhanced by the consumption
of a fermented milk product supplemented with L. acidophilus La1 and B. bifidum
Bb12 for 3 wk (Schiffrin and others 1995). Intake of baby formula containing viable
B. lactis was reported to increase IgA (Immunoglobulin A) level in healthy children
(Fukushima and others 1998).

It has been indicated that the enhanced immunity by

consumption of yogurt and LAB may contribute to the increased resistance to infection
and to the decreased incidence of gastrointestinal disorders, cancer and allergic
symptoms (Meydani and Ha 2000; Isolauri and others 2002).

Antimicrobial activity
The most notable benefit of yogurt and LAB is suppression of pathogens, by
which restoring normal microbial composition and functions in the intestinal tract.
Certain LAB such as L. acidophilus, L. bulgaricus and B. longum have been known for
their preventative and therapeutic effects against antibiotic-associated diarrhea
(Marteau and others 2002).

It has also been reported a shortening of rotavirus
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diarrhea in children by treatment with L. rhamnosus GG, L. reuteri, B. bifidum and S.
thermophilus (Saavedra and others 1994; Shornikova and others 1997; Guandalini and
others 2000).
In several in vitro studies, LAB cultures were inhibitory toward various harmful
bacteria, such as Escherichia coli O157:H7, Helicobacter pylori, Salmonella spp. and
Staphylococcus aureus (Kim and others 2003; Gagnon and others 2004; Millette and
others 2004). This beneficial effect has been associated to antimicrobial compounds,
such as organic acids and bacteriocins, by which conditions less favorable for
pathogenic bacteria and spoilage microorganisms were created (Lourens-Hattingh and
Viljoen 2001).

Organic acids, mainly lactic and acetic acids are metabolites of LAB.

Among all LAB produced organic acids, acetic acid showed strongest antimicrobial
activity, inhibiting a wild range of yeasts, molds and bacteria (Vandenbergh 1993;
Ouwehand and Vesterlund 2004). Bacteriocins are proteins or peptides secreted by
bacteria that inhibit the growth of other bacterial strains or species.

Lactic acid

bacteria produce various bacteriocins against other Gram- positive bacteria in genera
Bacillus, Clostridium, Enterococcus, Staphylococcus and Listeria (Klaenhammer
1993).

Nisin, a well-known example of LAB produced bacteriocin, has been used in
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food systems as a preservative (Hansen 1994; Sobrino-López and Martín-Belloso
2008).
In addition to producing antimicrobial compounds and enhancing immunity
activities, competitive inhibition by LAB has been proposed as another mechanism
found in LAB.

Probiotics may prevent harmful bacterial colonization in the intestinal

tract by competing essential nutrients for bacterial growth and for adhesion receptors in
the intestinal tract (Lourens-Hattingh and Viljoen 2001).
ability is strain and dose dependent.

However, the adhesion

Only a few probiotic strains, such as L.

acidophilus, L. casei, B. infantis and B. breve showed the adhesive properties to
enterocyte cell-line Caco-2 (Bernet and others 1993, 1994).

Anti-colorectal cancer effect
Colorectal cancer is cancer that occurs in the colon or rectum.

Colorectal cancer

is the third most common cancer after prostate and lung cancers and after breast and
lung cancers for men and women, respectively.

In the United States, colorectal

cancer is the second leading cause of cancer-related deaths (CDC 2007).

Some

studies have shown that LAB and their metabolites may have anti-colorectal cancer
effect (Wollowski and others 2001; Rafter 2002). Several postulated mechanisms
20

that reported to reduce the risk of colorectal cancer are: (i) Mutagen binding and
degradation (Rowland and Grasso 1975; Zhang and Ohta 1991; Orrhage and others
1994); (ii) Inhibition of carcinogen-producing enzymes, such as β-glucuronidase and
nitroreductase (McConnell and Tannock 1993; Ling and others 1994); and (iii)
Stimulation of immunity to better defend against cancer cells (Matsuzaki and others
2004).

Reduction in serum cholesterol
Cholesterol plays essential roles in human and animal body.

It acts as a

component of cell membranes and precursor to several vitamins and steroid hormones.
However, high levels of total blood cholesterol or low-density lipoproteins are
considered risk factors for developing coronary heart disease.

In animal trials,

feeding of L. acidophilus significantly reduced cholesterol levels in the serum of pigs
even fed with a high cholesterol diet (Gilliland and others 1985). Probiotics and
fermented milk products have also been reported to reduce serum cholesterol in
humans although the effects may be culture and strain dependent (Buck and Gilliland
1994; Taylor and Williams 1998; Sanders and Klaenhammer 2001).

Two mechanisms

responsible for lowering serum cholesterol have been postulated.

One theory is the
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ability of some LAB to assimilate cholesterol within bacterial cells and thus reduce the
amounts absorbed in blood.

Another possibility is that certain intestinal lactobacilli

can increase excretion of bile acids through hydrolyzation. Thus, the synthesis of
new bile acids from cholesterol in liver can indirectly lower cholesterol level in serum
(Gilliland and Speck 1977; Sanders 1999; Ray 2001).

Muscadine grapes
Muscadine grapes (Vitis rotundifolia) are the predominant grape species in the
southeastern United States and have been cultivated for more than 400 years.
Indigenous muscadines are now naturalized ‘from Delaware south along the Atlantic
coast to central Florida, west along the Gulf of Mexico to eastern Texas, north along
the Mississippi River to Missouri, and east to Delaware, with the exclusion of the
Appalachian Mountain areas’ (Olien 2001).

More than 95% of muscadine production

is in the southeastern coastal states. Among 15 muscadine-producing states, Georgia
(900 acres), North Carolina (660 acres), and Mississippi (600 acres) ranked top three in
muscadine production in 1988 (Olien 1990).

During the following years, the

production in both Georgia and North Carolina increased to more than 1300 acres.
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However, muscadine production in Mississippi decreased to 300 to 400 acres in 2005
(Cline and Fisk 2006; Coblentz 2007).
Compared to the European (Vitis vinifera) and American (Vitis labrusca) grapes,
muscadines are well adapted to the areas of hot and humid climate, having better
ability to resist Pierce’s bacterial disease (Chen and others 2001).

Unlike other bunch

grapes, muscadine fruits are developed individually within a loose cluster that ripens
over an extended period.

They are harvested from mid-August to mid-September in

Mississippi (Chen and others 2001; Coblentz 2007).
Muscadines have unique aroma and flavor, and are currently used for fresh table
grapes, wines, juices, jams and jellies, U-pick operations, and some functional
byproducts.

There are more than 100 different muscadine cultivars available for

home planting and commercial production (Mortensen 2001).

Usually, they are

divided into purple and bronze muscadines, based on the skin color. Purple to black
skinned muscadines, such as ‘Noble’ and ‘Ison’, are also called bullace, bull grape,
bullet grape etc.

‘Scuppernong’ is the traditional generic name for all bronze

muscadine, ‘Carlos’ and ‘Magnolia’ for examples. Actually, ‘Scuppernong’ is

23

probably the first bronze muscadine cultivar, named after the area in which it was
discovered (Olien 1990; Olien 2001).
Muscadines have been reported to contain nutritional and functional components
including vitamins, minerals, fiber, and polyphenolics (Ector 2001; Threlfall and others
2007).

In recent years, interest in the health benefits of muscadines has increased due

to their high phenolics contents, which has been proven to have excellent antioxidant
capacity (Pastrana-Bonilla and others 2003).

Phenolics in muscadines
The term “phenolic” or “polyphenolic” refers to general structures of molecules
which have aromatic rings bearing one or more hydroxyl groups, including functional
derivatives such as esters and glycosides.

The chemical structures of phenolic

compounds range from quite simple to highly complex.

The simple phenolic acids

include benzoic acid derivatives such as gallic acid, and cinnamic acid derivatives such
as caffeic acid.

Flavonoids are a group of phenolics having the skeleton of

diphenylpropanes with different oxidation level. Kaempferol, quercetin and catechin
are examples of flavonoids.

Stilbenes (such as resveratrol), lignans, and hydrolysable

and condensed tannins are other phenolics with highly polymerized structures.
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Phenolic compounds are secondary metabolites unique in higher plants, and serve as a
defense system against pathogens and environmental stress (Shahidi and Naczk 1995).
For example, resveratrol produced by Vitis species has been reported to resist fungal
infection and in response to ultraviolet irradiation and mechanical injury (Magee and
others 2002).
Most phenolics in grapes and muscadines are located in the seeds and skin
(Pastrana-Bonilla and others 2003).

Gallic acid, catechin and epicatechin are the

main phenolics found in muscadine seeds, while ellagic acid, myricetin, quercetin,
kaempferol and resveratrol are the major phenolics in the skin (Pastrana-Bonilla and
others 2003).

Overall, the major phenolics reported in muscadines are ellagic acid

(6.4-6.8mg/100g), kaempferol, myricetin and quercetin. Anthocyanins are the most
abundant flavonoids present in whole muscadines (Talcott and Lee 2002).

Total

anthocyanins range from 2 to 104 mg/L in muscadine juice, depending on cultivar skin
color, with red ones having the highest concentration (Threlfall and others 2007).
The presence of ellagic acid and anthocyanins in muscadines is unusual among
grape species (Lee and Talcott 2004).

However, anthocyanins and ellagic acid and

their derivatives are common phenolic compounds in berries, such as blueberries,
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raspberries

and

strawberries,

well-known

(Puupponen-Pimiä and others 2005c).

as

good

antioxidant

sources

Anthocyanins, primarily as 3, 5-diglucosides

in muscadine, appear as red or purple color substances in the skin.

Ellagic acid is a

dimeric derivative of gallic acid, and is believed to be formed by hydrolysis from its
conjugated forms like ellagic acid glycosides and ellagitannins in muscadines (Lee and
Talcott 2002).

Antioxidant capacity and other protective effects of phenolics
Positive correlation exists between total phenolics in fruits and vegetables and
their antioxidative activities (Velioglu and others 1998).

Total phenolics or individual

phenolic compounds either in berries or in grapes have been demonstrated to have
excellent antioxidant capacity (Kähkönen and others 2001; Pastrana-Bonilla and others
2003; Yilmaz and Toledo 2004).

They also have been correlated to the induction of

apoptosis, which inhibits growth of cancer cells (Mertens-Talcott and others 2006;
Seeram and others 2006), anti-inflammatory property (Greenspan and others 2005;
Bralley and others 2007), and antimicrobial activity (Puupponen-Pimiä and others
2001; Nohynek and others 2006).
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Velioglu and others (1998) believe that many protective effects of fruits and
vegetables are derived from their antioxidant functions. Plant-derived antioxidants
function as hydrogen donators, oxygen quenchers, free radical scavengers, peroxide
decomposers, metal chelators, enzyme inhibitors, and synergists (Wang and Lin 2000;
Puupponen-Pimiä and others 2001).

For example, grape seed extract containing

catechin and gallic acid, has been shown to prevent oxidative damage in tissues by
reducing lipid oxidation and/or blocking the production of free radicals (Yilmaz and
Toledo 2004).

The inhibitory effect of metalloproteinase of water extracts of

raspberries, blackberries and muscadines could contribute to their anticarcinogenesis
effect (Tate and others 2004).

The anticancer activity of muscadines may be partially

based on the ability to quench reactive oxygen species and the protection of critical
cellular components such as DNA, proteins, and lipids from oxidative damage
(Mertens-Talcott and others 2006).

In addition, combinations of phenolics are

presented in fruits and vegetables, and may be involved in synergistic interactions.
Ellagic acid and quercetin were reported to interact synergistically with resveratrol as
anticarcinogens (Mertens-Talcott and Percival 2005).
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Antimicrobial effect of phenolics
Berries and their phenolic compounds have also been shown to selectively control
several pathogens as natural antimicrobials, which maybe a resolution of antibiotic
resistance (Puupponen-Pimiä and others 2005b; Puupponen-Pimiä and others 2005c).
Some pure berry phenolics and berry extracts show inhibitory effect against tested
gastrointestinal Gram-negative pathogens, like Helicobacter pylori, Escherichia coli,
and Salmonella enterica.

However, the inhibition activity on Gram-positive bacteria

remains ambiguous in the literature.

Puupponen-Pimiä and others (2005a) reported

berry extracts might possess a selective inhibition effect on Gram-positive bacteria.
Berry phenolic compounds have antimicrobial effect on Staphylococcus aureus, but not
on all lactic acid bacteria (Puupponen-Pimiä and others 2001). It was reported that
cranberry (at 10mg extract per mL) is the only berry extract proven to affect Listeria
strains (Puupponen-Pimiä and others 2005c).

Overall, cloudberry, raspberry and

strawberry, which are rich in ellagitannins share the strongest inhibitory ability among
common Nordic berries (Puupponen-Pimiä and others 2005c; Nohynek and others
2006). So far, only one paper has been published to assess potential antimicrobial
effects of muscadines (Kim and others 2008b).
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They showed that water soluble

muscadine seed extracts with high concentration of tartaric acid has strong
antimicrobial activity on E. coli O157:H7.
It has been concluded that the complex mixture of phenolic compounds in berries
may affect different bacterial species by different mechanisms (Puupponen-Pimiä and
others 2005c; Heinonen 2007). First, the different cell surface structures between
Gram-positive and Gram-negative bacteria might limit the accessibility to berry
phenolics.

Some phenolic compounds have been reported to disintegrate the

lipopolysaccharide layer of the outer membrane and increase the permeability of
Gram-negative bacteria.

Cloudberry and raspberry extracts may disintegrate the

bacterial outer membrane and cause permeabilisation of Salmonella strains (Nohynek
and others 2006). Secondly, antiadhesion could block the adherence of bacteria to
epithelial cells, which is generally believed as an important virulence character in
bacterial infections.

Ellagitannins in cranberry have demonstrated possible bacterial

antiadhesion activity, and gives cranberry juice the ability to inhibit E. coli adherence
to

the

uroepithelium

(Puupponen-Pimiä

and

others

2005b).

Thirdly,

Puupponen-Pimiä and others (2005b) suggested that the degree of hydroxylation of
pure flavonols and flavones might affect their antibacterial activity. For example,

29

lactic acid bacteria are only inhibited by myricetin but not other more lipophilic
flavones (Puupponen-Pimiä and others 2005b).

Antimicrobial property of organic acids
Organic acids are known to have antimicrobial effect and are used as food
preservatives or additives.

Their effectiveness is dependent on the type and

concentration of acid, dissociation level, pH reduction, and the type of microorganisms
affected.

Among these factors, pH is considered a primary factor of antimicrobial

activity (Ricke 2003). At low pH (below pKa value of the acid), the acids exist in
their undissociated forms and may interact with or pass through the cell membrane,
which usually in microorganisms is negatively charged. Therefore, a low pH could
alter cell membrane permeability, and further lower the enzyme functions in
microorganisms and change their physiological status (Puupponen-Pimiä and others
2005b).

However, incorporation with other antimicrobial agents, phenolic acids for

example, yields better antibacterial activity than organic acids alone (Eswaranandam
and others 2004; Waite and Daeschel 2007).
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Effect of phenolic and organic acids on food quality
Astringency and bitterness of food products depends on their phenolic as well as
organic acid content. Both of them change as grape ripens.
content increases as fruit ripens (Lee and Talcott 2004).

Generally, phenolic

Tartaric and malic acids, the

most prominent organic acids in muscadine grapes, decrease during ripening
(Lamikanra and others 1995).
The 3, 5- anthocyanin diglucosides are unstable to oxidation and heat. The
anthocyanin degradation may be responsible for the color loss during juice or wine
storage (Doremus-Coign 1989; Talcott and Lee 2002). Also, ellagic acid has been
identified as the predominant component of the insoluble sediment, considered as a
quality defect in muscadine juice and wine (Lee and Talcott 2002).

Phenolics analysis by HPLC
Reversed-phase high performance liquid chromatography (RP-HPLC) with
ultraviolet detection has been utilized to analyze many food components, including
organic acids and phenolic compounds, with high sensitivity (Lee 2000; Talcott 2003).
The mobile phase, a relatively polar buffer, such as water, methanol, or acetonitrile,
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changes to a continuous gradient during detection.

The stationary phase is relatively

nonpolar, such as silica-based C18 column.
For phenolic compound detection, either acid or alkaline hydrolysis is necessary
to separate the free phenolic acids from their conjugated form in the samples during the
preparation steps.

The separation of the phenolic components is based on their

relative hydrophobicity.

The elution and separation of phenolic compounds by

RP-HPLC is in a decreasing polarity order (Harborne 1998; Lee 2000).

Their

identification and quantification involve comparing the retention time and peak area of
interest to those of pure standards. The results are often presented in milligrams per
milliliter or gram of food sample (Talcott 2003).
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Figure 2.1 Number of publications per year on Enterobacter sakazakii in databases
PubMed and AGRICOLA.
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CHAPTER III
ANTAGONISTIC EFFECT OF YOGURT LACTIC ACID BACTERIA
AGAINST ENTEROBACTER SAKAZAKII

Abstract
Yogurt, one the most popular carriers of lactic acid bacteria (LAB), is known to
exhibit antagonistic activity against human pathogens and also maintain healthiness of
the gastrointestinal system.

The objective of this study was to evaluate the

antagonistic effect of yogurt LAB against Enterobacter sakazakii. In agar spot tests,
yogurt sample containing LAB at 106 CFU/g were antagonistic toward E. sakazakii
strains Fec39 and MSDH.

The clear zones, indicating inhibitory effect, were

significantly bigger with decreased concentration of inoculated E. sakazakii. In the
simulated gastric model, the D value of E. sakazakii (90.5 min) was lower than that of
LAB (about 148 min) when pH dropped below 3.0.

The recovery of viable E.

sakazakii was significantly higher than that of LAB after being transferred to the
simulated small intestinal compartment.
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Yogurt LAB were able to survive through

the simulated GI model; however, the expected inhibitory effect of yogurt toward E.
sakazakii was not clear in this model. A lower initial concentration of E. sakazakii, as
well as competitive adhesion ability to intestinal epithelium may be considered for
further study.

Introduction
Enterobacter sakazakii is a member of the Enterobacteriaceae family, genus
Cronobacter. It is a gram-negative, motile, non-spore forming, facultative anaerobic
bacillus.

It has been considered an emerging opportunistic pathogen causing rare but

life threatening meningitis, necrotizing enterocolitis, and sepsis in infants (Iversen and
Forsythe 2003).

Among 111 reported cases of E. sakazakii infection worldwide from

1958 to 2005, at least 26 deaths were reported in infants and children (Mullane and
others 2007).

Irreversible neurological consequence and retarded neural development

have been commonly found in meningitis survivors (Lai 2001). Outbreaks of E.
sakazakii infections have been associated with the ingestion of contaminated powdered
infant formula (Iversen and Forsythe 2003). Although the pathogenesis mechanism
of E. sakazakii is still unclear, the gastrointestinal (GI) tract is believed a portal of
entry of this bacterium. The adherence and invasion capacity of E. sakazakii to
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intestinal epithelial cells have also been reported (Mange and others 2006; Mohan Nair
and Venkitanarayanan 2007).
Lactic acid bacteria cultures were inhibitory toward various harmful bacteria,
such as Bacillus, Clostridium, Enterococcus, Escherichia coli O157:H7, Helicobacter
pylori, Listeria, Salmonella, and Staphylococcus aureus (Klaenhammer 1993; Kim and
others 2003; Gagnon and others 2004; Millette and others 2004).

The antimicrobial

effect of LAB, especially those classified as probiotics, may due to the production of
organic acids and other antimicrobial compounds, enhancing immunity activities, and
competitive exclusion of pathogens (Bernet and others 1993; Klaenhammer 1993;
Vandenbergh 1993; Collado and others 2006).

Probiotics have been clinically

demonstrated to be effective therapeutic agents by reducing the incidence of diarrhea
in humans (Saavedra and others 1994; Shornikova and others 1997).
Survival of the gastrointestinal (GI) transit is one of the preconditions for bacteria
to develop beneficial effects or to cause diseases. After consumption, bacteria should
be able to survive the low stomach pH and tolerate the bile salts in the duodenum (Lick
and others 2001).

Several simulated GI models have been established with simulated

gastric and intestinal juice as alternative to the human GI tract, which is relatively
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inaccessible and a difficult area to investigate (Minekus and others 1995; Marteau and
others 1997; Koo and others 2001).
This study was designed to evaluate the effectiveness of yogurt, the most popular
carrier of LAB, on inhibiting E. sakazakii in the agar spot test and in a simulated GI
model.

The ability of yogurt lactic acid bacteria and E. sakazakii to resist GI transit

in vitro by simulation means was also determined.

Materials and Methods

Chemicals and media
All chemicals used in this study were purchased from Sigma-Aldrich Inc. (St.
Louis, MO) and Fisher Scientific Inc. (Pittsburgh, PA), unless otherwise noted.

All

culture media and ingredients used for bacteria maintaining, dilution, and enumeration
were obtained from Difco Laboratories (Sparks, MD).

Bacterial strains and yogurt sample
Enterobacter sakazakii strains Fec39 and MSDH, Lactobacillus bulgaricus LL18,
and L. helveticus CNRZ32 used in this study were provided by Dr. Yoshen Chen
(Mississippi State University).

Cultures of E. sakazakii were grown in Bacto tryptic
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soy broth (TSB) at 37˚C for 12 h, and cultures of Lactobacillus in Bacto Lactobacilli
MRS broth (MRS) at 37˚C in a BD GasPack EZ anaerobe container system (Becton,
Dickinson and Company, Sparks, MD) for 12 h. All cultures were held at 4˚C as
stock cultures, and transferred to fresh broth to maintain bacterial viability.
Commercial nonfat plain yogurt (Great Value; marketed by Wal-Mart Stores, Inc.,
Bentonville, AR) labeled to contain Lactobacillus acidophilus, L. bulgaricus,
Streptococcus thermophilus, and Bifidobacterium logum was purchased from local
stores (Starkville, MS).

The yogurt sample was stored at 7℃ and used for studies

before the sell by date.

Agar spot test
A modified agar spot test (Gagnon and others 2004) was used to examine the
antagonistic effect between LAB and E. sakazakii.
with 0.1% peptone solution.

Yogurt was diluted at 1:100 (w/v)

Pure cultures of L. bulgaricus LL18 and L. helveticus

CNRZ32 were grown in MRS broth at 1% (v/v) inoculation and incubated
anaerobically at 37℃ for 12 h.
on 1.5% MRS agar plates.

A 2 μL portion of each LAB sample was first spotted
Plates were dried at room temperature for 30 min,

incubated anaerobically at 37 ℃ for 18 h, and overlaid with 10 mL soft agar
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containing E. sakazakii.

The overlaid inoculum was prepared by adding full growth

E. sakazakii cultures (37˚C in TSB for 12 h) into TSB containing 0.85% agar at 0.01,
0.1, and 1% ratio (v/v) to obtain final concentrations of 104~106 CFU/mL.

After

incubation at 37 ℃ for 18 h, the zones of clear agar around the LAB spots on the
plates were measured.

Simulated gastrointestinal (GI) model
To determine the antagonistic activity of yogurt LAB against E. sakazakii, a
simulated GI model (Marteau and others 1997; Koo and others 2001) with some
modifications was also used in this study. As shown in Figure 3.1, two stainless steel
containers with closure lids (Royal House Hold Products Inc., Cerritos, CA) were used
to represent the gastric and small intestine compartments, respectively.

A sterile

1,000 mL Pyrex beaker with a sterile magnetic stirring bar was placed inside of each
compartment.

The two containers were then placed in an acrylic open bath (UDY Co.;

Fort Collins, CO) with a heating immersion circulator (Julabo E-BASIS; Julabo
Labortechnik GmbH, Seelbach, Germany) to maintain the temperature of the water
bath at 40℃.

Two magnetic stirrers (Fisher aluminum-top stirring hotplate; Fisher

Scientific Inc.) were set under the open bath for mixing the GI contents at the lowest
39

speed.

For gastric emptying, the half-time was 60 min (Ghoos and others 1993) up to

3 h (Table 3.1). As shown in Table 3.1, the pH curve in the gastric compartment was
controlled to reproduce the values found in humans after consumption: pH 5.0 at
initiation and pH 4.1, 3.0, 2.1, and 1.8 at 20, 40, 60, 80 min, respectively (Conway and
others 1987). In the small intestinal compartment, the pH value was kept around 6.5.
The pH of GI the contents was measured with a Corning Pinnacle 530 pH meter
(Corning Inc., Corning, NY).

An unscented tea light candle (Id Williamsburgh

Candle Corp., NY) was placed next to the beaker and burned each time before closing
the container to create an oxygen limited environment.
To prepare the E. sakazakii sample, 1 mL full growth broth of E. sakazakii Fec39
was centrifuged (Eppendorf Centrifuge 5415C; Hamburg, Germany) at 13,000rpm for
1min.

After discarding the supernatant, 1 mL sterile milk (8.5 g Similac infant

formula (Abbott Laboratories. Abbott Park, IL) / 60 mL water) was added to mix with
the pellet and then mixed with 9 mL sterile milk.

Ten grams of yogurt and/or E.

sakazakii sample were diluted (1:1, w/v or v/v) with sterile electrolyte solution (6.2g of
NaCl, 2.2g of KCl, 0.22g of CaCl2, and 1.2g of NaHCO3 per liter of distilled water) to
simulate the in vivo dilution by saliva.

This mixture was introduced into the gastric
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compartment followed by the addition of simulated gastric fluid which containing 0.1g
of pepsin, 3.5g of mucin, and 8.5g of NaCl per liter of sterile distilled water, adjusted
to pH 1.6 to 1.7 with 1N HCl.
A 9.9 mL portion of simulated small intestinal juice containing 0.1 g of trypsin
and 3.5 g of pancreatin per liter of sterile distilled water was added into the simulated
intestinal compartment at the transition time 0 h.

The pH was maintained around 6.5

with 0.1M NaHCO3 initially, and with 0.3M NaHCO3 for the rest of the experiment.
In addition, a 12.5 mL of 4% bile extract solution was added at the beginning, and the
bile concentration was maintained at 1.55% with 2% bile extract solution for the
remaining time.
It was considered as transition time zero when yogurt and/or E. sakazakii samples
were first added to the simulated gastric or being transferred to the small intestinal
compartment.

To study the viability of bacterial cells in the gastric compartment,

gastric contents were aseptically sampled and analyzed at gastric transition times 0, 20,
40, 60, 80, 120, and 180 min. To exam the viable bacterial cells in the small intestinal
compartment, the content was sampled and analyzed at intestinal transition time in
30-min periods for the first hour and in 60-min periods for the remaining 8 h.
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Contents from gastric and small intestinal compartments at each defined time
point were serially diluted with 0.1% peptone solution.

Pour plating with Bacto M17

agar with 0.5% β-lactose and Bacto Lactobacilli MRS agar was used for lactic
streptococci and lactobacilli enumeration, respectively. The viable LAB were then
enumerated after 3-day anaerobic incubation at 37℃.

Viable E. sakazakii Fec39 were

enumerated on tryptic soy agar after 18~24 h incubation at 37℃.

The viable bacterial

cell counts were divided by a dilution factor to take the added volumes of simulated
fluids into consideration. The dilution factor of each sampling transition time equaled
the contents remaining (mL) in each compartment divided by the combined volume
(mL) of the remaining contents and all added simulated fluids (NaHCO3 and bile
solution in simulated small intestine).

Statistical analysis
A 2 (E. sakazakii strains) * 3 (E. sakazakii concentrations)* 3 (LAB samples)
factorial arrangement in a completely randomized design with three replications was
used to analyze the inhibition zone in the agar spot test. Also, a two-way factorial
arrangement (samples * transition times) in a split-plot design was used for analyzing
the antagonistic effect in the simulated GI model.
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Data obtained from triplicate

samples were analyzed using PROC GLM procedure, means were separated by
Fisher’s protected LSD (P < 0.05), and the slopes of viable E. sakazakii which used to
further determine decimal reduction time (D value) in the simulated gastric model were
obtained by linear regression analysis (PROC REG) with SAS program version 9.1
(SAS Institute, Cary, NC).

Results

Antagonistic effect between lactic acid bacteria and Enterobacter sakazakii
The clear zones around the spots of yogurt and LAB indicated the antagonistic
activity against E. sakazakii.

All Lactobacillus spp. and yogurt sample were

antagonistic toward E. sakazakii to varying degrees (Table 3.2). As the concentration
of E. sakazakii decreased, the diameters of clear inhibition zones were significantly
larger.

The average diameters of inhibition zones were 12.8, 10.9, and 8.8 mm when

0.01, 0.1, and 1% of E. sakazakii (104~106CFU/mL) were inoculated, respectively.
Generally, there were no significant differences between the two tested E. sakazakii
strains.

Two lactic acid cultures, L. helveticus CNRZ32 and L. bulgaricus LL18, at

about 108 CFU/mL showed significantly stronger antagonistic effect against E.

43

sakazakii than 1:100 diluted yogurt (about 106 CFU/mL) did. The average diameters
of clear zones produced by L. helveticus CNRZ32, L. bulgaricus LL18, and diluted
yogurt were 11.6, 11.8, and 10.3 mm, respectively.

Viabilities of lactic acid bacteria in yogurt and Enterobacter sakazakii in the
simulated GI model
The bars in Figures 3.2 - 3.9 were the mean values of the viable cells of yogurt
LAB and E. sakazakii Fec39 in the simulated GI model expressed in decimal
logarithms.

Both Lactobacillus and Streptococcus in yogurt sample as well as E.

sakazakii showed similar patterns of decrease in the simulated gastric model (Figures
3.2, 3.4, and 3.6).

After 180 min in the simulated gastric model, there were 5.5-5.9

log CFU/mL reductions of viable cells of Lactobacillus and E. sakazakii, regardless of
the form of sample introduced to the simulated GI model.

The survival rate of

bacteria in the simulated gastric model (Table 3.3) equaled the viable cell numbers at
the endpoint (transition time: 180 min) divided by the initial (transition time: 0 min)
cell numbers.

There were no significant differences of the survival rates among all

bacterial cells detected in the simulated gastric model, including the survival rate of E.
sakazakii in the sample combined yogurt with lower initial E. sakazakii.
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With the severe decrease in pH, all viable cells decreased rapidly in 40-80 min in
the gastric transit (Figures 3.2, 3.4, 3.6 and 3.8). The slope of the decreased pH value
was -0.060 (log CFU/ min) during 40-80 min in the gastric model, while it was -0.018
(log CFU/ min) during the whole 180 min in the gastric model.

The D values

obtained during 40-80 min were significantly lower than that obtained during 0-180
min in the simulated model (Table 3.4). Lactobacillus spp. and Streptococcus in
yogurt showed significantly higher D values than E. sakazakii did.
All the gastric contents were transferred to the simulated small intestinal
compartment during the gastric transition time: 60-180 min, which was overlapped
with the intestinal transition time: 0-2 h.

The viable cells of E. sakazakii and yogurt

LAB showed an increased trend during 3-9 h in the simulated small intestinal model
(Figures 3.3, 3.5, 3.7 and 3.9). The survival rate of bacteria in the small intestine
equaled to the viable cell number at the endpoint (intestinal transition time: 9 h)
divided by the initial (gastric transition time: 0 min) cell number.

Enterobacter

sakazakii demonstrated significant higher survival rate in the simulated intestinal
model than yogurt LAB did.

An approximate 90% recovery of E. sakazakii was

noted after passing through the simulated GI model, while less than 70% of yogurt
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LAB were recovered. Although the survival rates of E. sakazakii at the final endpoint
between samples (with or without yogurt) did not differ, the D value of E. sakazakii in
the samples combined with yogurt was significantly higher than that of E. sakazakii
when introduced to the GI model alone.

Discussion and Conclusion
There is no clear evidence of a minimal infectious dose of E. sakazakii in humans.
An estimated 1,000 CFU/mL proposed by Iversen and Forsythe (2003) was based on
the infectious dose of E. coli O157:H7 and Listeria monocytogenes. The results of
the agar spot tests showed that yogurt and LAB were able to inhibit up to 106 CFU/mL
of E. sakazakii, although the inhibitory effectiveness of LAB may depend on the
concentration of pathogens and LAB.

It has been suggested that the antagonistic

effect of LAB may be due to the production of antimicrobial substances such as
organic acids (Gagnon and others 2004). Organic acids may lower the pH and create
conditions less desirable for harmful bacteria.

Competition for nutrients necessary for

bacterial growth in the environment has also been reported as another possible
antimicrobial mechanism of LAB (Lourens-Hattingh and Viljoen 2001). These
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factors may explain the antagonistic results demonstrated by the agar spot tests in this
experiment.
An approximate 35% of the ingested LAB in yogurt samples remained viable
after 180 min in the gastric compartment in this study.

However, Marteau and others

(1997) reported that L. bulgaricus and S. thermophilus fell below 1% of the ingested
numbers within 70 and 110 min in a simulated stomach.

Some probiotics were

believed to have stronger antimicrobial effect and better survivability in gastric (acid)
condition than other LAB (Meydani and Ha 2000; Millette and others 2004).

Among

Lactobacillus spp., L. acidophilus is more resistant to gastric juice than the yogurt
starter culture, L. bulgaricus, and is more resistant than S. thermophilus (Meydani and
Ha 2000).

Lactobacillus acidophilus and Bifidobacterium longum, two well known

probiotics, claimed by the commercial yogurt used in this test may be responsible for
the observed results. To achieve the therapeutic benefits, the minimum probiotic
consumption number of 108 live cells per day was suggested (Tamime and others
1995). Consumption of more than 100 g yogurt containing 106 viable cells per day
would provide these number (Rybka and Kailasapathy 1995; Tamime and others 1995;
Lourens-Hattingh and Viljoen 2001).
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The viability of LAB and E. sakazakii varies with gastric pH.

Viable counts of

both Lactobacillus and Streptococcus in the yogurt rapidly decreased after transition
time 40 min in the gastric compartment, when the pH was below 3.

Conway and

others (1987) showed similar results of the test of bacterial strains in
phosphate-buffered saline solution at various pH. The lower D value in the gastric
model indicated that E. sakazakii was more sensitive to acid than were yogurt LAB.
Shaker and others (2008) reported that the populations of inoculated E. sakazakii
decreased significantly during the last few hours of yogurt fermentation and during
cooling and storage of yogurt (pH 4.2-4.7).

Edelson-Mannel and others (2006)

studied the acid resistance among 12 strains of E. sakazakii in TSB with various
adjusted pH for 5 h.

At pH 3.0, the decline of viable E. sakazakii ranged from 4.9 to

>6.3 log CFU/mL, while most strains showed only 1 log CFU/mL reduction at pH 3.5.
However, it has been reported that the less acidic stomach of newborns, especially that
of prematures, and the buffering capacity provided by ingested milk may contribute to
survival and infection of E. sakazakii in infants (Forsythe 2005; Lenati and others
2008).

Therefore, acidification was suggested to lower the concentration of E.

sakazakii in baby foods (Joosten and Lardeau 2004; Lin and Beuchat 2007).
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The lethality of bile salt on LAB and E. sakazakii may be lower than the effect of
gastric acid in the simulated GI model.

All bacterial cells detected showed increasing

trend in the small intestinal transit after serious decline under the acid gastric condition.
However, E. sakazakii had better recovery than that of LAB in the intestinal model,
where pH was maintained around 6.5.

There was no significant antagonistic effect of

yogurt against E. sakazakii at concentrations 105 and 108 CFU/mL in the simulated GI
model.

However, it was reported that yogurt consumption may increase the numbers

of stool anaerobes, predominantly bifidobacteria to suppress coliform, one of the
genera of the family Enterobacteriaceae (Chen and others 1999).

This contradiction

may happen due to the higher initial inoculum amount (higher than the estimated
minimal infectious dose 1,000 CFU/mL) of E. sakazakii.

Also, it is probably due to

the dilution of the organic acids and antimicrobial compounds, hypothesized earlier, by
the fluid in the GI tract.

Besides, the ability of LAB to adhere to the intestinal

epithelium is another important parameter influencing the antimicrobial effect toward
pathogens (Bernet and others 1993, 1994; Parvez and others 2006). Therefore, the
adhesion ability and the competitive exclusion effect of yogurt LAB against E.
sakazakii should be further determined.
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Figure 3.1 Simulated gastrointestinal model: (1) stainless steel container, (2)
Pyrex beaker with magnetic stirring bar, (3) water bath, (4)
heating immersion circulator, (5) magnetic stirrer, and (6) candle.
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Table 3.1

The controlled pH values and the transfer of gastric contents in the
simulated gastrointestinal model
Gastric model

Transition time (min)

0

20

40

60

80

120 180

pH control

5.0

4.1

3.0

2.1

1.8

1.8

1.8

*

**

Contents transferred to

*

“Intestinal model”

Intestinal model
Transition time (h)

0

0.5

1

2

3

4

5

6

7

8

9

pH control

6.5

6.5

6.5

6.5

6.5

6.5

6.5

6.5

6.5

6.5

6.5

*

**

Contents transferred
from “Gastric model”

*

* At this transition time point, half of the gastric contents were transferred from the
gastric compartment to the intestinal compartment.
** At this transition time point, all of the gastric contents were transferred from the
gastric compartment to the intestinal compartment.
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0.01%

10.3 ± 1.5 A, b 12.8 ± 1.8 A, a
11.3 ± 2.8 A, ab 13.9 ± 2.7 A, a
11.2 ± 2.7 A, a 13.0 ± 2.7 A, a

0.1%
8.1 ± 1.3 B, c
9.2 ± 0.7 AB, a
9.8 ± 2.1 A, a

1%

0.01%
9.6 ± 1.4 B, b 12.3 ± 1.2 AB, a
11.8 ± 2.3 AB, a 14.1 ± 3.0 A, a
12.2 ± 2.3 A, a 13.0 ± 2.1 A, a

0.1%

E. sakazakii MSDH

* Values within columns having the same capital letters are not significantly different (P<0.05).
Values within rows having the same small letters are not significantly different (P<0.05).

Diluted yogurt (1:100) 8.2 ± 0.8 A, c*
L. helveticus CNRZ32 9.0 ± 1.4 A, b
L. bulgaricus LL18
9.8 ± 1.8 A, a

1%

E. sakazakii Fec 39

Inhibition zone diameter (mm)

Table 3.2 Antagonistic effect of yogurt and Lactobacillus spp. on Enterobacter sakazakii as demonstrated by the agar spot test
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Figure 3.2 Viable yogurt lactic acid bacteria and pH in simulated gastric model.
Means sharing the same letters are not significantly different (P<0.05).

53

7

8

6
5

6

4

4

3

pH value

Viable cells (log CFU/mL)

10

2

2

1

0

0
0

0.5

1

2

3

4

5

6

7

8

9

Transition time (h)
Lactobacilli

Streptococci

pH

Figure 3.3 Viable yogurt lactic acid bacteria and pH in simulated intestinal model.
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Figure 3.4 Viable Enterobacter sakazakii Fec39 and pH in simulated gastric model.
Means sharing the same letters are not significantly different (P<0.05).
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Figure 3.5

pH

Viable Enterobacter sakazakii Fec39 and pH in simulated intestinal
model.
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Figure 3.6

E. sakazakii

pH

Viable yogurt Lactobacillus and Enterobacter sakazakii Fec39 (108
CFU/mL initial inoculation) and pH in simulated gastric model. Means
sharing the same letters are not significantly different (P<0.05).
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Viable yogurt Lactobacillus and Enterobacter sakazakii Fec39 (108
CFU/mL initial inoculation) and pH in simulated intestinal model.
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Viable yogurt Lactobacillus and Enterobacter sakazakii Fec39 (105
CFU/mL initial inoculation) and pH in simulated gastric model. Means
sharing the same letters are not significantly different (P<0.05).
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Viable yogurt Lactobacillus and Enterobacter sakazakii Fec39 (105
CFU/mL initial inoculation) and pH in simulated intestinal model.

60

61
9.3
8.6
9.3
9.2

Yogurt alone
Yogurt with high levels of E. sakazakii
Yogurt with low levels of E. sakazakii

Yogurt alone

E. sakazakii

Lactobacillus

Streptococcus

3.3

3.3
3.1
3.4

2.3
3.1
2.1

Endpoint in
G†

6.4

6.0
7.0
7.4

7.5
7.8
4.8

Endpoint in
I†

* Values within columns having the same letters are not significantly different (P<0.05).
†
G stands for the simulated gastric model, and I stands for the simulated intestinal model.

8.1
8.1
5.4

Initial

E. sakazakii alone
Yogurt with high levels of E. sakazakii
Yogurt with low levels of E. sakazakii

Samples introduced to GI model

Viable cells (log CFU/ mL)

35.9 a

35.5 a
36.0 a
36.6 a

28.4 a*
38.3 a
38.9 a

Endpoint in
G†

69.6 b

64.5 b
81.4 ab
79.6 ab

92.6 a
96.3 a
88.9 a

Endpoint in
I†

Survival rate (%)

Table 3.3 Viability and survival rate of Enterobacter sakazakii and yogurt LAB in the simulated gastrointestinal model

Table 3.4 Decimal reduction times (D values) of Enterobacter sakazakii and yogurt
LAB in the simulated gastric model

Samples introduced to GI model

D values (min)
0-180 min

40-80 min

E. sakazakii alone

177.3

90.5

Yogurt with high levels of E. sakazakii

208.4

103.9

Yogurt with low levels of E. sakazakii

426.3

102.0

Lactobacillus

Yogurt alone

234.8

149.6

Streptococcus

Yogurt alone

236.2

146.2

E. sakazakii
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CHAPTER IV
ANTIMICROBIAL EFFECT OF MUSCADINE JUICES
ON ENTEROBACTER SAKAZAKII

Abstract
Muscadine grapes (Vitis rotundifolia Michx.) have been reported to have high
polyphenol content and great antioxidant capacity, but little research has been
conducted to assess potential antimicrobial effects of muscadines.

In this study, red

and white muscadine juices and commercial baby juices were investigated for
inhibition of Enterobacter sakazakii. Major phenolic compounds and organic acids in
juices were also identified and quantified by HPLC. There were only 0.2 to 1.4-log
reductions of E. sakazakii in commercial baby juices, while 6-log reductions of E.
sakazakii cells were achieved by muscadine juices within 2-hour incubation at 37°C.
Overall, among all tested juices, red muscadine juices which had lower pH values and
were higher in tartaric acid, total phenolics and major phenolic acids contents
demonstrated the strongest antimicrobial effect.
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These results suggest that muscadine

juices may be utilized as natural antimicrobial agents in baby foods to control the
growth of E. sakazakii.

Introduction
Enterobacter sakazakii is considered as an emerging opportunistic pathogen,
causing rare but life threatening meningitis, bacteremia, and necrotizing enterocolitis in
infants (Nazarowec-White and Farber 1997a; Lai 2001).

Ingestion of contaminated

powdered infant formula has been implicated in several clinical outbreaks in neonates
and infants (Iversen and Forsythe 2003).

The gastrointestinal tract has been

suggested as the portal of entry among patients with Enterobacter spp. bacteremia, and
meningitis is believed to occur by translocation of invasive bacteria (Pagotto and
others 2003; Mange and others 2006).

The less acidic stomach and the more

permeable intestinal tracts of infants may make them most susceptible to E. sakazakii
(Lenati and others 2008).
Muscadine grapes (Vitis rotundifolia) have the ability to tolerate hot, humid
climates, and resistant to Pierce’s disease, and they are the predominant grape species
grown in the southeastern United States (Chen and others 2001).

Recently, interest in

the health benefits of muscadines has increased due to their high phenolics’ content
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(Pastrana-Bonilla and others 2003; Yilmaz and Toledo 2004), excellent antioxidant
capacity (Pastrana-Bonilla and others 2003; Lee and Talcott 2004), anti-cancer
properties

(Yi

and

others

2005;

Mertens-Talcott

and

others

2006),

and

anti-inflammatory activity (Greenspan and others 2005; Bralley and others 2007).
The presence of ellagic acid in muscadines is unique among grape species.

But,

ellagic acid and its derivatives are common phenolic compounds in berries, such as
blueberries, raspberries and strawberries, which have been demonstrated to possess
strong antimicrobial activity (Puupponen-Pimiä and others 2001; Nohynek and others
2006).

Other than phenolics, muscadine grapes also contain nutritional and

functional components such as vitamins, minerals, fiber, and organic acids (Ector 2001;
Threlfall and others 2007).

Organic acids, like tartaric and malic acids, have been

reported to inhibit foodborne pathogens (Eswaranandam and others 2004; Waite and
Daeschel 2007). An earlier study demonstrated the antimicrobial effects of tartaric
acid against Escherichia coli O157:H7 (Kim and others 2008b).
The antimicrobial effects against Salmonella typhimurium, Staphylococcus aureus,
Escherichia coli, Pseudomonas, Bacillus, Micrococcus, and Proteus spp. of orange
juice, yogurt, and the combination of orange juice with yogurt have been demonstrated
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(Mothershaw and Jaffer 2004). Low pH was then suggested to contribute to the
inhibitory activity through creating conditions less desirable for these harmful bacteria.
Since E. sakazakii were not acid resistance bacteria (Edelson-Mammel and others
2006), lower pH may also decrease its survivability.

Considering the potential

inhibition effect and the convenience to deliver to infants, muscadine juices were
investigated for their antimicrobial effect against E. sakazakii.

The antimicrobial

effect via the combination of muscadine juices and yogurt, a common lactic acid
bacteria carrier, was also evaluated.

Materials and Methods

Chemicals and reagents
Folin & Ciocalteu’s phenol reagent, sodium carbonate and pure standards of gallic
acid (90% purity), (+)-catechin (95% purity), (-)-epicatechin (90% purity), ellagic acid
(95% purity), myricetin (85% purity), quercetin (98%) purity, trans-resveratrol (95%
purity), L-malic acid, and tannic acid were purchased from Sigma-Aldrich Inc. (St.
Louis, MO). Tartaric acid, acetic acid, hydrochloric acid, sulfuric acid, acetonitrile,
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methanol, and HPLC grade water were purchased from Fisher Scientific Inc.
(Pittsburgh, PA).

Juice preparation
Two varieties of fresh muscadine juices were donated by the Mississippi
Agricultural and Forestry Experiment Station (MAFES), Mississippi State University.
Red muscadine juice (hot-pressed) was processed from purple grape cultivar ‘Noble’,
while white juice (cold-pressed) was obtained from a mixture of bronze grape cultivars
‘Carlos’ and ‘Magnolia’. Fresh juices were divided into portions in 50mL sterile
centrifuge tubes (Fisher Scientific Inc.) and except the juices for pasteurization, and
were stored at -20°C until use or further treatments.
To prepare the pasteurized juice samples, frozen muscadine juices were thawed at
room temperature until no floating ice was observed, and then heated with constantly
stirring in an open steam kettle in the Ammerman-Hearnsberger pilot plant,
Department of Food Science, Nutrition and Health Promotion, Mississippi State
University.

The juices were held at 90°C for one minute and then filled into

pre-sterile Pyrex media bottles (Corning Inc., Corning, NY).

After cooling in a

refrigerator overnight, the pasteurized muscadine juices were stored at -20°C until use.
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Both frozen (fresh and pasteurized) muscadine juices were thawed in a refrigerator
overnight, and used within 3 days.
After thawing in a refrigerator overnight, the hot sterile juice samples were
prepared by autoclaving (121°C, 103.4 kPa) the juices in a screw-capped vial (National
Scientific Co., Rockwood, TN) for 15 min. In contrast, the cold sterile muscadine
juices were obtained by filtration with a 0.20 µm syringe filter (Millipore, Bedford,
MA).

Both hot and cold sterile juice samples were stored in a 7°C refrigerator until

use.
Three types of commercial baby juices (Gerber Products Co., Fremont, MI) were
purchased from local stores (Starkville, MS) and used as reference juice samples in this
study.

The white grape and apple grape juices were made from juice concentrate, and

the mixed berry juice was made from juice and puree concentrates (Table 4.1). Once
the bottles were opened, all commercial baby juices were transferred from room
temperature (about 25°C) to a refrigerator at 7°C, and the opened baby juice samples
were no longer used and discarded after 3-days storage in the refrigerator.
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Total phenolics
Juice samples were diluted appropriately with deionized water and analyzed for
total phenolics according to the Folin-Ciocalteu procedure (Waterhouse 2001).
Absorption at 765nm was measured in a Spectornic genesys 5 UV-vis
spectrophotometer (Fisher Scientific Inc.).

The total phenolics were expressed as

milligrams of gallic acid equivalents per milliliter of juice.

Soluble solids concentration and pH
The soluble solids concentration was measured using Bausch & Lomb
Refractometer 33.46.10 (Bauch & Lomb Inc., Rochester, NY).

The temperature was

maintained at 20°C with cold water circulating through the refractometer during the
measurement.

After calibration with deionized water before each reading, one drop

(about 300 μL) of juice samples was placed on the glass prism.

The readings were

recorded and expressed as °Brix.
The pH values of juices were measured at room temperature (about 25°C) with a
Corning Pinnacle 530 pH meter (Corning Inc.).
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Major phenolic and organic compounds
Reversed-phase high-performance liquid chromatography (HPLC) was used to
separate and quantify major phenolics and organic acids in juices. Juice samples
were mixed with 6 N HCl at 1:10 ratio (v/v) and placed in a water bath for one hour to
separate the free phenolic acids from their conjugated forms (Lee 2000).

After

cooling to room temperature (about 15 min), each supernatant of acid hydrolyzed
samples was filtered through a 0.45 µm syringe filter (Millipore, Bedford, MA) and
injected into a Gemini C18, 250 x 4.6 mm column (Phenomenex Inc., Torrance, CA) in
an Agilent HPLC 1100 series (Agilent Technologies Inc., Santa Clara, CA) equipped
with a diode array detector.

The injected volumes of samples were 25 μL.

The two

mobile phases were solvent A: methanol/acetic acid/water (10:2:88, v/v/v), and solvent
B: acetonitrile.

A linear gradient for phenolics separation was used as follows: at 0

min, 95% solvent A, 5% solvent B; at 1 min, 90% solvent A, 10% solvent B; at 30 min,
30% solvent A, 70% solvent B; at 31 min, 90% solvent A, 10% solvent B; at 32 min,
95% solvent A, 5% solvent B with 5 min post run.
Individual phenolics were detected at 260 nm.
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The flow rate was 1 mL/min.

To separate organic acids, muscadine juices were centrifuged at 12,000 rpm
(1,700 g) for 5 min, and each supernatant was filtered and injected into a HPLC system
as described above. The mobile phase was 0.01 N H2SO4 with a flow rate of 1
mL/min.

Individual organic acids were detected at 215 nm.

Peaks for phenolic compounds and organic acids were integrated and analyzed
using the ChemStation software (Agilent Technologies Inc.).

Individual compounds

were quantified based on the retention times and peak area of the standards.

Antimicrobial activity
Enterobacter sakazakii Fec39 and E. sakazakii MSDH (provided by Dr. Yoshen
Chen, Mississippi State University) were used in this study. After incubation at 37°C
in tryptic soy broth (Difco Laboratories, Sparks, MD) for seven hours, the bacterial
cultures were added to the juice samples at a 1:1000 ratio (v/v) giving an initial 106
cells per milliliter inoculnum. The inoculnum was incubated at 37°C, and the viable
cells were recorded every 30 min, for up to 120 min.

Viable E. sakazakii were

enumerated on tryptic soy agar plates (Difco Laboratories) after incubation at 37°C for
18 to 24 h.
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In addition, commercial yogurt as described in chapter III was purchased from
local stores (Starkville, MS), and was also incorporated into muscadine juices to
examine the combined antimicrobial effect.

After mixing yogurt sample with

pasteurized muscadine juices, E. sakazakii were then inoculated to the mixtures. The
viable cells of E. sakazakii in the mixtures were enumerated as described above.

Statistical analysis
Data of pH, total phenolics, phenolic compounds, and organic acids of the
muscadine juices were analyzed using a 2 (muscadine cultivars) * 4 (juice treatments)
factorial in a randomized complete block design, while a completely randomized
design was used to compare muscadine juices with commercial baby juice samples.
A two-way factorial design (treatments x time) was used for measurement of
antimicrobial activity. Also, a two-way factorial design (juices x bacteria) and linear
regression analysis (PROC REG) was used for decimal reduction time (D value)
calculation. Data obtained from at least three replications (except soluble solids)
were analyzed by PROC GLM, and means of the variables were separated by Fisher’s
protected LSD (P< 0.05) using SAS 9.1 (SAS Institute, Cary, NC).
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Results

Soluble solids, pH, total phenolics, organic acids, and phenolic acids in juices
The soluble solids expressed as °Brix, pH, and organic acids in muscadine and
commercial baby juices were presented in Table 4.2.

Overall, both muscadine juices

were lower (P<0.05) in malic acid content and pH, and were higher in tartaric and
tannic acid than commercial baby juices.

Red muscadine juices (RMJ) showed lower

pH and °Brix (P<0.05) and higher contents of tartaric and tannic acids than white
muscadine juices (WMJ).

RMJ and commercial mixed berry (MB) juice

demonstrated the highest concentrations of total phenolics, followed by commercial
apple grape (AP), white grape (WP), and then WMJ.

Among the major phenolic

compounds detected, the ellagic acid concentration was 7-11 times higher in RMJ than
in WMJ and commercial baby juices (Table 4.3).

Also, RMJ were higher (P<0.05) in

gallic acid and epicatechin contents than WMJ. There were no consistent trends
between treatments of muscadine juices on all characteristics detected.
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Antimicrobial activity on Enterobacter sakazakii
The antimicrobial activity of muscadine juices against E. sakazakii was measured
in liquid cultures by the plate count method, and experimental results are shown in
Figures 4.1 and 4.2. Within two hours, both strains of E. sakazakii were reduced to
non-detectable levels in all muscadine juices. There were about 6-log reductions in
cell number regardless of the muscadine juice type or treatments.

During the first 0.5

h in muscadine juices, the decrease in the viable E. sakazakii cells showed a lag trend.
Thus, the D values were calculated based on the viable E. sakazakii changes from 0.5 h
to the time no viable cells were detectable (Table 4.4).

Overall, the lower D values of

RMJ indicated that RMJ had stronger antimicrobial effect against E. sakazakii than
WMJ did (P<0.05).

Pasteurized muscadine juices were less effective against E.

sakazakii than both cold and hot sterile juices.
In contrast, there were only 0.2 to 1.4-log reductions of E. sakazakii in inoculated
commercial baby juices within four hours (Figure 4.3). Among three baby juices,
mixed berry juice demonstrated better antimicrobial effect than white grape and apple
grape juices. However, there were no differences between the susceptibility between E.
sakazakii Fec39 and MSDH to either muscadine or commercial baby juices.
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Commercial nonfat plain yogurt was added into pasteurized muscadine juices at
1:10 ratio (w/v) giving an initial 108 CFU of lactic acid bacteria per milliliter
inoculation.

In this mixture of yogurt and pasteurized muscadine juice, there were ca.

2-log and 6-log reductions of E. sakazakii in two and four hours, respectively (Figure
4.4).

No significant differences in E. sakazakii log reduction were observed between

red and white muscadine juices when combined with yogurt.

Within four hours,

lactic acid bacteria were reduced about 2-log in viable cell numbers either in
muscadine juices and/or in the mixture of juices and yogurt (Figure 4.5).

The

differences of the viable yogurt lactic acid bacteria among six various samples were
not significant.

Discussion and Conclusion
Hot pressing, heating prior to pressing, is commonly used in juice processing with
dark grapes, including dark-skinned muscadines. This technique has been reported to
increase juice yield, color, acids, color pigments and other nutraceutical components
(Auw and others 1996; Threlfall and others 2005; Leblanc and others 2008). For
white/bronze muscadines, hot pressing procedures were often linked to browning
reactions affecting juice quality (Lee and Talcott 2004).
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Comparing to those in WMJ,

the observed higher contents of total phenolics, epicatechin, and tartaric, tannic, ellagic,
and gallic acids in red muscadine ‘Noble’ juice may be derived from the differences in
the muscadine cultivar and/or juice pressing method, and may be possible reasons for
the stronger antimicrobial activity.
Pasteurization is commonly used in the food industry to extend the shelf life of
acidic foods by inactivating enzymes and microorganisms.

However, the effects of

heat treatment on phenolic contents were contradictory in the literature.

Del

Pozo-Insfran and others (2006) reported that thermal pasteurization decreased
anthocyanins, soluble phenolics, and antioxidant capacity in muscadine juices, whereas
other researchers reported that heat treatment may increase the concentration of certain
phenolic compounds in juices due to the hydrolysis of higher molecular weight
compounds (Dawes and Keene 1999; Musingo and others 2001).

Stojanovic (2008)

found that anthocyanins, phenolics, and antioxidant activity of blueberry juices were
not affected by hot fill pasteurization.

In this study, pasteurization treatment

increased the contents of tannic and tartaric acids in RMJ and WMJ, respectively.
The other changes between treatments were not consistent in the contents of organic
acids and phenolic compounds.

Comparing the antimicrobial effect with both cold
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and hot sterile muscadine juices, pasteurized juices had diminished antimicrobial effect
against E. sakazakii. However, a burned brown color was observed in hot sterile
(autoclaved) juices due to extensive high temperature exposure, and it should not be
used for juice processing.

Cold sterile juices obtained by filter clarification were

reported to caused the loss of compounds linked to the proteins, and therefore the
lowered concentrations of anthocyanins and pigment destruction were reported
(Bakker and others 1992; Wrolstad and others 1994).

Some alternative processing

techniques other than thermal processing, like high hydrostatic pressure, pulsed electric
field, and dense phase CO2 processing (Talcott and others 2003; Del Pozo-Insfran and
others 2006; Del Pozo-Insfran and others 2007; Stojanovic 2008) have been proposed
and may be used to examine their effect on juice quality and antimicrobial effect.
It has been suggested that E. sakazakii were sensitive to acidic or acidified food
products. Kim and Beucahat (2005) reported that E. sakazakii grew in tomato juice
(pH 4.4) and watermelon juice (pH 5.1), but did not grow in apple juice (pH 4.0) or
strawberry juice (pH 3.5) stored at 25°C. Richards and others (2005) also showed
that infant rice cereal reconstituted with apple juice (pH 4.32) did not support the
growth of E. sakazakii. Enterobacter sakazakii was also found to grow at the early

77

stage but declined at the end of the yogurt fermentation process probably due to
increasing concentration in lactic acid (Shaker and others 2008).

In the current study,

a trend was observed that the juices with lower pH values have the better antimicrobial
effects.

The RMJ (pH 3.18) followed by WMJ (pH 3.37) showed better inhibitory

ability than mixed berry juice (pH 3.52) and other baby juices (pH around 3.6).
Generally, at low pH, the organic acids exist in their undissociated forms and may
interact with or pass through the bacterial cell membrane.

Through altering the cell

membrane permeability, decreasing enzyme functions, and other physiological changes
in bacteria may cause cell death (Puupponen-Pimiä and others 2005b). In addition,
there are differences between commercial baby juices and muscadine juices in organic
acid contents.

Tartaric and tannic acids, the stronger bacterial inhibitors, were the

major organic acid in both RMJ and WMJ, while malic acid was the dominant one in
commercial baby juices.
Since the pH values of commercial baby juices (3.52-3.67) were lower than those
effective pH (3.5-4.32) described in the literature, some other factors may be interfere in
their antimicrobial activity. All the commercial baby juices tested in this study were
made from concentrates, which are commonly used in the commercial fruit juices
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(Bengoechea and others 1997).

The processing procedures of juice concentration,

reconstitution, and pasteurization for final products may contribute to the relatively lower
antimicrobial activity of commercial baby juices. It has been suggested that although
products may be high in phenolic compounds and antioxidant activity, the
antiproliferation and other bioactivity activities of blueberry juices may be diminished by
harsh processing methods, including spray-dried and juice concentration (Schmidt and
others 2005).
Although only one study has been conducted on the antimicrobial effect of
muscadines, various berries with similar phenolics profiles to muscadines have been
proven to possess antimicrobial effects against several pathogens, e.g. Helicobacter
pylori, E. coli, Salmonella enterica, and Staphylococcus aureus (Puupponen-Pimiä and
others 2005a; Kim and others 2008b).

In the current study, total phenolics contents

were high in RMJ and mixed berry baby juice. Other than the differences in pH and
organic acids, the concentrations of total phenolics, gallic and ellagic acids, and
epicatechin were higher in RMJ than in WMJ. Among the three commercial baby
juices, mixed berry juice, which demonstrated better antimicrobial effects, had higher
total phenolics contents than white grape and apple grape baby juices.
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Thus, total

phenolics and some phenolic acids may also contribute to the inhibition effect against
E. sakazakii.

Nohynek and others (2006) suggested that disintegrating the bacterial

outer membrane and increasing the permeability of bacterial cells observed in
cloudberry and raspberry extracts may be one possible mechanism causing bacterial
death.

Antiadhesion, blocking the adherence of bacteria to epithelial cells, has also

been demonstrated by Puupponen-Pimiä and others (2005b) as another possible
antimicrobial mechanism of phenolics.
Berry phenolic compounds have selective inhibitory effect on human pathogens,
but Bifidobacterium and several strains of Lactobacillus spp. were not affected
(Puupponen-Pimiä and others 2001; Puupponen-Pimiä and others 2005c). In this
study, yogurt lactic acid bacteria (2-log reduction in four hours) were less affected by
muscadine juice than E. sakazakii (6-log reduction in two hours).

However, the

mixture of yogurt and muscadine juice was less effective against E. sakazakii than
muscadine juice alone.

The milk-based proteins and sugars in yogurt may provide

buffering capacity (the pH value rose from 3.18 to 3.28 in muscadine juices to 3.5 of
for mixture), and contributed to the prolonged eradication time of E. sakazakii. Since
some strains of probiotics have been proven to inhibit and displace preadhered E.
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sakazakii, it was suggested that the inclusion of probiotics in infant formula is a
possible way to improve the resistance to these gastrointestinal pathogens when
breastfeeding is not possible (Collado and others 2006; Collado and others 2008).

In

addition, in order to prevent rapid microbial growth in infant formula, acidification,
either through fermentation with lactic acid bacteria or by direct addition of lactic acid,
has been proposed by Josten and Lardeau (2004).
In conclusion, muscadine juice, a rich source of phenolics and organic acids,
demonstrated strong antimicrobial effect against E. sakazakii.

All inoculated E.

sakazakii were eradicated within 2 and 4 h in muscadine juices and muscadine juice
combined with yogurt, respectively. Comparing juices from two muscadine cultivars,
red muscadine ‘Noble’ juices were lower in pH, had higher concentrations of total
phenolics, tartaric, tannic, gallic, and ellagic acids, and epicatechin, and showed better
antimicrobial effect.
sterile juices.

Pasteurized juices showed lower D values than cold and hot

The commercial baby juices had higher pH and lower tartaric and

tannic acids contents, and the effects on E. sakazakii were not clear. These results
suggest that muscadine juices or in forms incorporated with lactic acid bacteria may
have the potential to be used in baby food as a natural E. sakazakii inhibitor.
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Table 4.1

Ingredients labeled in the commercial baby juices used in this study

Baby juices

Ingredients

Other information labeled

Apples grape juice

Grape juice concentrate
Apple juice concentrate
Water
Ascorbic acid (vitamin C)

No added sweeteners
No preservatives
No artificial flavors or colors

White grape juice

White grape juice concentrate
Water
Ascorbic acid (vitamin C)
Citric acid

No added sweeteners
No preservatives
No artificial flavors or colors

Nature Sips mixed
berry (just for
toddlers)

Apple puree concentrate
Blackberry puree
Blueberry puree
Grape juice concentrate
White grape juice concentrate
Blueberry juice concentrate
Blackberry juice concentrate
Ascorbic acid (vitamin C)
Alpha-tocopheryl acetate
(vitamin E)
Water
Natural flavor

Real fruit smoothies
Naturally flavored with natural
flavors
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AG *
MB *
WG *

Average

Fresh
Cold Sterile
Hot Sterile
Pasteurization

Average

Fresh
Cold Sterile
Hot Sterile
Pasteurization

Treatment/
Flavor

13.4
15.8
17.4

20.1

20.1
20.2
19.8
20.4

16.0

16.3
16.2
15.4
16.0

Solids (˚Brix)

Soluble
†

3.67 A
3.52 B
3.61 A

3.28±0.07 C

3.23 bc
3.25 b
3.25 b
3.37 a

3.18±0.04 D

3.16 c
3.16 c
3.19 bc
3.22 bc

pH

210.7 B
347.7 A
176.7 C

57.7±11.1 D

60.2 b
50.3 b
64.4 b
56.9 b

325.4±27.7 A

338.4 a
319.4 a
321.6 a
322.9 a

Total Phenolics

0.67 D
0.99 D
1.67 C

2.79±0.43 B

2.25 c
2.75 c
2.74 c
3.32 b

4.25±0.68 A

3.37 b
4.27 a
4.48 a
4.65 a

(mg/mL)

Tartaric acid

4.45 A
3.62 B
2.87 C

1.38±0.39 D

1.20 b
1.25 ab
1.88 a
1.27 ab

1.53±0.55 D

1.27 ab
1.60 ab
1.78 ab
1.48 ab

Malic acid

ND

ND

ND*

0.29±0.04 B

0.25 c
0.30 c
0.32 c
0.31 c

1.71±0.27 A

1.71 a
1.90 a
1.83 a
1.41 b

Tannic acid

Means of muscadine juices followed by a different small letter differ (P<0.05).
Means of average muscadine juices and commercial baby juices followed by a different capital letter differ (P<0.05).
* RMJ (red muscadine juice), WMJ (white muscadine juice), AG (apple grape juice), MB (mixed berry juice), WG (white grape
juice), and ND (not detected).

†

Commercial
Baby Juices

WMJ *

RMJ *

Juice

Table 4.2 Soluble solids, pH, total phenolics, and organic acids in red muscadine, white muscadine, and commercial juices
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21.1 a
20.2 a
18.0 ab

Cold sterile
Hot sterile
Pasteurization

13.9 bc
13.9 bc
12.4 cd

Cold sterile
Hot sterile
Pasteurization
32.5 A
29.7 A
26.7 A

36.4±21.4 A

48.1 ab
45.7 ab
27.9 ab

21.1 b

48.4±15.4 A

54.0 a
53.4 a
43.0 ab
43.2 ab

Catechin

46.5 A
46.2 A
14.5 C

20.8±4.3 B

22.9 b
24.6 b
16.8 b

17.4 b

49.1±11.2 A

53.7 a
50.7 a
47.6 a
43.9 a

Ellagic acid

2.60 B
3.17 B
2.20 B

3.4±1.8 B

4.9 b
3.0 b
3.1 b

3.1 b

25.9±7.5 A

24.4 a
29.1 a
25.5 a
24.0 a

(mg/100mL)

Epicatechin

0.56 A
0.70 A
0.63 A

0.5±0.2 A

0.4 b
0.5 b
0.6 ab

ND *

0.9±0.6 A

1.1 a
0.5 b
1.4 a
0.9 ab

Myricetin

0.9 b
1.3 ab
0.6 b
1.7 a

Quercetin

1.2 ab
0.2 c
1.2 ab

ND

5.05 AB
2.10 B
6.93 A

ND
ND
0.4 A

3.1±1.5 B 0.9±0.6 A

3.4 a
3.3 a
2.4 a

3.1 a

4.3±1.3 AB 1.1±0.7 A

3.8 a
4.6 a
4.4 a
4.4 a

Resveratrol

Means of muscadine juices followed by a different small letter differ (P<0.05).
Means of average muscadine juices and commercial baby juices followed by a different capital letter differ (P<0.05).
* RMJ (red muscadine juice), WMJ (white muscadine juice), ND (not detected).

†

17.7 AB
19.7 A
22.8 A

Average 12.4±4.1 B

8.6 d

Fresh

Average 20.3±2.9 A

21.6 a

†

Gallic acid

Fresh

Flavor

Treatment/

Apple Grape
Commercial
Mixed Berry
Baby Juice
White Grape

WMJ*

RMJ*

Juice

Table 4.3 Major phenolic compounds in red muscadine, white muscadine, and commercial juices
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Figure 4.1 Viable cells of (A) Enterobacter sakazakii Fec39 and (B) E. sakazakii MSDH in red muscadine juices. Different
treatments are showed as: (●) pasteurization, (▲) hot sterile, () cold sterile. (*) shows control growth curve of
E. sakazakii in tryptic soy broth.
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Viable cells of (A) Enterobacter sakazakii Fec39 and (B) E. sakazakii MSDH in white muscadine juices.
Different treatments are showed as: (●) pasteurization, (▲) hot sterile, () cold sterile. (*) shows control growth
curve of E. sakazakii in tryptic soy broth.
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Table 4.4

Decimal reduction times (D values) for Enterobacter sakazakii in
muscadine juices
D values (min) for E. sakazakii

Juices

Red muscadine juices

White muscadine juices

Treatments

E. sakazakii Fec39

E. sakazakii MSDH

Cold sterile
Hot sterile
Pasteurization

53.5
69.7
74.5

71.9
74.8
76.9

Average

65.9

74.5

Cold sterile
Hot sterile
Pasteurization

72.7
53.3
106.7

69.5
52.9
106.6

Average

77.6

76.3
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Figure 4.3 Viable cells of (A) Enterobacter sakazakii Fec39 and (B) E. sakazakii MSDH in commercial baby juices: apple
grape juice (Δ), white grape juice (○), and mixed berry juice (□). (*) shows control growth curve of E. sakazakii
in tryptic soy broth.
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Figure 4.4 Viable cells of (A) Enterobacter sakazakii Fec39 and (B) E. sakazakii MSDH in pasteurized red muscadine juice
(Δ), yogurt mixed with pasteurized muscadine juice (▲), pasteurized white muscadine juice (□), yogurt mixed
with white pasteurized muscadine juice (). (*) shows control growth curve of E. sakazakii in tryptic soy broth.
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Viable yogurt lactic acid bacteria in various muscadine juices with yogurt added and
with/without E. sakazakii inoculated. (*) shows viable lactic acid bacteria in 0.1% peptone
solution. RMJ stands for red pasteurized muscadine juice, and WMJ is white pasteurized
muscadine juice.
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CHAPTER V
ANTIMICROBIAL EFFECT OF MUSCADINE SEED EXTRACTS
ON ENTEROBACTER SAKAZAKII

Abstract
Muscadine grapes (Vitis rotundifolia) are recognized for their high polyphenol
contents and their antioxidant capacity, but little research has been conducted to assess
their potential antimicrobial properties.

Seed extracts from two muscadine cultivars

(bronze and purple) along with two extraction methods were investigated for their
inhibition of Enterobacter sakazakii.

The relationships between the composition of

muscadine seed extracts and their antimicrobial effects were also evaluated.

Within

two hours, viable E. sakazakii in all seed extracts were reduced to non-detectable
levels, except in the cold ‘Carlos’ (bronze) seed extract. In general, ‘Ison’ (purple)
seed extracts demonstrated stronger inhibition ability to E. sakazakii, had lower pH,
and were higher in organic acids, phenolic contents, and total phenolics.

Ellagic,

tannic, and gallic acids, which increased under hot extraction, may play a key role in
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the antimicrobial effect on E. sakazakii.

Results suggested that muscadine seed

extracts might be a great natural antimicrobial agent for baby foods and other products.

Introduction
Enterobacter sakazakii is a Gram-negative, motile bacterium that is considered an
emerging opportunistic pathogen. It causes meningitis and necrotizing enterocolitis
in infants with high mortality rates, up to 40-80% and 10-55%, respectively. The
meningitis survivors often develop irreversible neurological sequela (Lai 2001; Kim
and others 2008a).

Outbreaks of E. sakazakii infections have been associated with

the ingestion of infant formula (Iversen and Forsythe 2003).

Although E. sakazakii

exists in powdered infant formula at less than 1 cell per 100g in most positive samples
(Muytjens and others 1988; Nazarowec-White and Farber 1997b), this bacterium has
been found to grow rapidly in reconstituted infant formula at temperatures between 5.5
to 47˚C (Nazarowec-White and Farber 1997b; Forsythe 2005; Kandhai and others
2006).
Muscadine grape (Vitis rotundifolia) is native to the southeastern United States.
In recent years, interest in the health benefits of muscadines has increased due to their
high phenolic contents (Pastrana-Bonilla and others 2003; Yilmaz and Toledo 2004).
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The major phenolics in muscadines are ellagic acid and its derivatives, which are
unique among grape species.

There compounds are common in berries, such as

blueberries, raspberries and strawberries (Pastrana-Bonilla and others 2003; Lee and
Talcott 2004).

Muscadines and its phenolics compounds have demonstrated excellent

antioxidant capacity (Pastrana-Bonilla and others 2003; Lee and Talcott 2004),
anti-cancer properties (Yi and others 2005; Mertens-Talcott and others 2006),
anti-inflammatory activity (Greenspan and others 2005; Bralley and others 2007), and
antimicrobial activity on E. coli O157:H7 (Kim and others 2008b).
The muscadine seed, which accounts for 1.5 to 9.2% of whole fruit, is considered
a by-product in juice and winery processing (Pastrana-Bonilla and others 2003).
Pastrana-Bonilla and others (2003) reported most phenolics in grapes and muscadines
are located in the skin and seeds.

It has also been reported that dried muscadine seeds

have the highest contents of total phenolics and oxygen radical absorbance substances
compared to dried skins, whole grapes, and the juice (Striegler and others 2005).
Grapes (Viris vinifera) and their by-products have been reported to possess the
antimicrobial effect on Listeria monocytogenes, E. coli O157:H7, Staphylococcus
aureus, and several Bacillus spp. (Jayaprakasha and others 2003; Özkan and others
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2004; Rhodes and others 2006).

Several reports have revealed that grape seed

extracts combined with nisin can be used as natural preservatives to control Listeria
monocytogenes on ready-to-eat products (Theivendran and others 2006; Sivarooban
and others 2007).

However, no studies have reported on their effect on E. sakazakii.

Therefore, this research is designed to investigate (i) the organic acid and phenolics
composition of muscadine seed extracts from two cultivars and the composition
differences as affected by two extraction methods, (ii) the inhibition effects of
muscadine seed extracts against E. sakazakii, and (iii) to correlate the composition
profile of muscadine seed extracts with the antimicrobial effect.

Materials and Methods

Chemicals and reagents
Folin & Ciocalteu’s phenol reagent, sodium carbonate and pure standards of gallic
acid (90% purity), (+)-catechin (95% purity), (-)-epicatechin (90% purity), ellagic acid
(95% purity), malic acid and tannic acid were purchased from Sigma-Aldrich Inc. (St.
Louis, MO). Tartaric acid, acetic acid, hydrochloric acid, sulfuric acid, acetonitrile,
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methanol, and water (ACS reagent grade) were purchased from Fisher Scientific Inc.
(Pittsburgh, PA).

Seed extract preparation
Ground ‘Carlos’ (bronze-skinned) and ‘Ison’ (black-skinned) muscadine seed
powders were provided by a local fruit grower (Starkville, MS).
were kept at -20°C in the dark until further analysis.

Both seed powders

To prepare the hot seed extract,

one gram of seed powder was first mixed with 5 mL deionized water in a screw-capped
vial (National Scientific Co., TN).

The mixture was autoclaved (121°C, 103.4 kPa)

for 15 min, mixed in a rotary mixer (Dynal Inc., NY) at 40 rpm for one hour at room
temperature, and centrifuged at 17,000 x g for 5 min (Eppendorf centrifuge 5415C;
Brinkmann Instruments, NY). The supernatant was then filtered through a 0.20 μm
syringe filter (Millipore, Bedford, MA). The cold seed extract was prepared as the
hot extraction method without autoclaving.

Total phenolics and pH
The pH of muscadine seed extracts were measured using a pH meter (Corning
Pinnacle 530; Corning Inc., Corning, NY) at room temperature.
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Total phenolics were

determined according to the Folin-Ciocalteu procedure (Waterhouse 2001).
Appropriately diluted samples were mixed with Folin & Ciocalteu’s phenol reagent
and sodium carbonate and allowed to stand for two hours. Absorbance at 765nm was
measured in a Spectronic Genesys 5 UV-vis spectrophotometer (Fisher Scientific Inc.).
Results were expressed as milligrams of gallic acid equivalents per milliliter of seed
extract.

Organic

and

phenolic

acids

detection

by

high-performance

liquid

chromatographic (HPLC) analysis
Reversed-phase HPLC was used to separate and quantify major phenolic
compounds and organic acids in muscadine seed extracts.

Extract samples were

mixed with 6 N HCl at 1:10 ratio (v/v) and placed in a water bath for one hour to
separate the free phenolic acids from their conjugated forms (Lee 2000).

After

cooling down to room temperature (about 15 min), each supernatant of acid
hydrolyzed samples was filtered through a 0.45 µm syringe filter (Millipore, Bedford,
MA) and injected into a Gemini C18, 250 x 4.6 mm column (Phenomenex Inc.,
Torrance, CA) in an Agilent HPLC 1100 (Agilent Technnologies Inc., Santa Clara, CA)
equipped with a diode array detector.

The injected volume of samples was 25 μL.
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The two mobile phases were solvent A: methanol/acetic acid/water (10:2:88, v/v/v),
and solvent B: acetonitrile.

A linear gradient for phenolics separation was used as

follows: at 0 min, 95% solvent A, 5% solvent B; at 1 min, 90% solvent A, 10% solvent
B; at 30 min, 30% solvent A, 70% solvent B; at 31 min, 90% solvent A, 10% solvent B;
at 32 min, 95% solvent A, 5% solvent B with 5 min post run.
mL/min.

The flow rate was 1

Individual phenolic compounds were detected at 260 nm.

To separate tartaric, malic and tannic acids, muscadine seed extracts were
centrifuged at 12,000 rpm (1,700 g) for 5 min, and the supernatants were filtered and
injected into the HPLC system as described above.
H2SO4 with a flow rate of 1 mL/min.

The mobile phase was 0.01 N

Individual organic acids were detected at 215

nm.
Peaks for phenolic compounds and organic acids were integrated and analyzed
using the ChemStation software (Agilent Technologies Inc.).

Individual compounds

were quantified based on the retention times and peak area of the standards.

Antimicrobial activity
Enterobacter sakazakii Fec39 and E. sakazakii MSDH (provided by Dr. Yoshen
Chen, Mississippi State University) were used in this study. After incubation at 37°C
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in tryptic soy broth (Difco Laboratories, Sparks, MD) for seven hours, the bacterial
cultures were added into muscadine seed extracts at a 1:1000 ratio (v/v) giving an
initial 106 CFU per milliliter inoculation. The inoculum was incubated at 37°C, and
the viable cells were recorded every 30 min for up to 120 min.

Viable E. sakazakii

were enumerated on tryptic soy agar plates (Difco Laboratories) after incubation at
37°C for 18 to 24 h.

Statistical design and analysis
A 2 (muscadine cultivars) * 2 (extraction methods) factorial in a randomized
complete block design with three replications was used for detecting pH, total
phenolics, organic acids, and phenolic compounds. To measure the antimicrobial
activity, a two-way factorial design (treatments x times) was used. Fisher’s protected
LSD (P< 0.05) used to separate means, Linear regression analysis used for D value
determine, Pearson correlations used to analyze the relationship between E. sakazakii
log reduction and components in muscadine seed extract, and analysis of variance were
carried out with SAS 9.1 (SAS Institute, Cary, NC).
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Results

pH and total phenolics, organic acid and phenolic acid contents in seed extracts
Tartaric acid was the major organic acid, while gallic acid had the highest
concentration among the detected phenolic acids in muscadine seed extracts (Table
5.1). ‘Ison’ seed extracts had lower pH, and was higher in organic acids than ‘Carlos’
muscadine seed extract.

Overall, total phenolics, gallic and ellagic acids were

generally higher in ‘Ison’ seed extracts than those in ‘Carlos’ seed extracts.

Hot

extracts had lower pH and higher concentrations of total phenolics, malic, tannic,
ellagic acids, and epicatechin than cold extracts regardless of the cultivar.

Antimicrobial activity of extracts on Enterobacter sakazakii
Within two hours incubation, both strains of E. sakazakii were reduced to
non-detectable levels, about a 6-log reduction, in most muscadine seed extracts (Figure
5.1).

Overall, ‘Ison’ seed extracts and hot extractions demonstrated stronger

antimicrobial effect than ‘Carlos’ seed extracts and cold extractions, respectively.
The hot ‘Ison’ seed extract had the stronger antimicrobial effect on E. sakazakii while
the cold ‘Carlos’ seed extract had the weakest activity.

99

However, the inhibition

effects of seed extracts between the two tested bacterial strains were similar.
The decimal reduction times (D values) were calculated based on the slop of the
linear trend line of viable E. sakazakii log reduction.

Ison seed extracts showed lower

D values, which means better antimicrobial effect than Carlos seed extracts (Table 5.2).
The D values of seed extracts prepared by hot extraction method were lower than those
prepared by cold extraction.

Pearson correlation
Pearson correlations were used to examine the relationships between muscadine
seed extract components and viable E. sakazakii cell reduction.

The determination

coefficient (R2) and probability (p) were presented in Table 5.3. The log reduction
showed a negative correlation with pH (R2 = -0.855), whereas positive determination
coefficient were showed with other components of muscadine seed extract.

Ellagic,

tannic, gallic, malic, and tartaric acids, and pH showed low probability (p< 0.01) with
high determination coefficient (R2).
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Discussion and Conclusion
The minimal infective dose of E. sakazakii was estimated to be 1,000 CFU/mL
based on the infectious dose of E. coli O157:H7 and Listeria monocytogenes (Iversen
and Forsythe 2003; Lehner and Stephan 2004).

In the present study, E. sakazakii cells

at 106 CFU/mL were inactivated to non-detectable levels by most muscadine seed
extracts within 90 min.

Also, heat treatment increased the concentrations or organic

acids and phenolics, and enhanced their antimicrobial activity of muscadine seed
extracts.

Heat treatment has been reported to increase several low molecular weight

phenolic compounds and the antioxidant activity of citrus peel extracts (Jeong and
others 2004).

Thus, heat treated muscadine seed extracts may potentially serve as

antimicrobials to control E. sakazakii.
The characteristics and the antimicrobial effects of muscadine juices observed in
the previous chapter were compared with the results of muscadine seed extracts.

The

hot seed extract was higher in tartaric and tannic acids contents than muscadine juice,
but the pH values remained similar. Among all detected phenolic compounds, the
seed extracts were only higher in gallic acid contents.
phenolics compounds were similar or lower.
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The amounts of other

Especially, the total phenolics

concentrations were much lower in the seed extracts.

Although the inoculated E.

sakazakii at 6-log CFU were inhibited to non-detectable level with 2 h in most
muscadine juices and seed extracts, hot ‘Ison’ seed extracts has been demonstrated the
fastest antimicrobial activity on E. sakazakii.
Several researchers have suggested that acidification may lower the concentration
of E. sakazakii in food products. Comparing infant rice cereal reconstituted with
water and milk, cereal reconstituted with apple juice at pH 4.29 did not support the
growth of inoculated E. sakazakii (Richards and others 2005).

Kim and Beuchat

(2005) reported E. sakazakii grew in cantaloupe, watermelon, carrot, cucumber, and
lettuce juices, but not in apple and strawberry juices.

Also, they suggested that low

initial pH values of apple and strawberry juices may be the major factor in preventing
growth of E. sakazakii (Kim and Beuchat 2005). Kim and others (2008b) reported
that 5.6-log reduction of E. coli O157:H7 was achieved by 10.7 mg/mL tartaric acid
alone, the major organic acid in muscadine seed extracts.

However, the authors also

suggested that other compounds may be involved in the antimicrobial activity since
tartaric acid alone did not inactivate E. coli as much as the whole seed extracts did.
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Since the poor solubility of many phenolic compounds has been suggested to limit
the determination of the antimicrobial effect and the minimum inhibitory concentration
of individual phenolic compounds on pathogens (Puupponen-Pimiä and others 2005b),
the correlation analysis was performed to predict the relationship between the detected
components in muscadine seed extracts and the E. sakazakii log reduction.

The

results showed factors, other than tartaric acid, may be highly correlated to the E.
sakazakii log reduction.

The antimicrobial activity on E. sakazakii by the muscadine

seed extracts correlated well with the increase of ellagic, tannic, gallic, malic, and
tartaric acids and with the decrease of pH.
Ellagic acid is a dimeric derivative of gallic acid, and is believed to be formed by
hydrolysis from its conjugated forms like ellagic acid glycosides and ellagitannins in
muscadines (Lee and Talcott 2002). Ellagitannins and gallotannins (esters of gallic
acid and glucose) are two major groups of hydrolysable tannins, commonly referred as
to tannic acid (Akiyama and others 2001).

Tannins have been reported to inhibit a

wide range of fungi, yeasts, viruses and foodborne bacteria, including Enterobacter
aerogenes, E. coli, Listeria monocytogenes, Salmonella enteritidis, S. paratyphi,
Shigella flexnier and Stapylococcus aureus etc. (Chung and others 1998b).
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The

inhibitory effect of tannins on microorganisms may be owed to their strong binding
capacity to iron, which is critical for the survival of bacteria (Chung and others 1998a).
Cloudberry and raspberry extracts, which are rich in ellagitannins, may disintegrate the
bacterial outer membrane and cause permeabilisation of Salmonella strains (Nohynek
and others 2006).

Also, ellagitannins in cranberry have demonstrated possible

bacterial antiadhesion activities, and give cranberry juice the ability to inhibit E.
coli )157:H7 adherence to the uroepithelium (Puupponen-Pimiä and others 2005b).
In conclusion, muscadine seed extracts have low pH and are rich sources of
phenolic compounds and organic acids, which together contribute to great
antimicrobial effects on E. sakazakii.

Tannic acid and its’ derivatives, ellagitannins

and gallotannins, might play a key role in the observed antimicrobial effect.

These

results revealed that muscadine seed extracts may act as potential natural antimicrobial
agents.

Before being added to baby foods or used in pharmaceutical industry, further

studies are needed to determine the minimum inhibitory concentration of muscadine
seed extracts, and to evaluate their sensory characteristics and safety.
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Table 5.1 pH, total phenolics, organic acids, and major phenolics concentration of
muscadine seed extracts
Muscadine cultivars
Ison

Carlos

Extraction methods

Extraction methods

Cold

Hot

Cold

Hot

pH

3.37c *

3.30 c

3.78 a

3.69 b

Total phenolics (mg/mL)

2.11 c

3.45 a

1.51 d

2.64 b

Individual compounds
Tartaric acid (mg/mL)
Malic acid (mg/mL)
Tannic acid (mg/mL)
Gallic acid (mg/100 mL)
Catechin (mg/100 mL)
Epicatechin (mg/100 mL)
Ellagic acid (mg/100 mL)

7.23 a
1.43 b
5.25 b
26 ab
11 a
5c
9b

7.55 a
1.89 a
8.58 a
35 a
18 a
10 a
17 a

3.88 b
1.10 b
2.27 c
11 b
7a
5 bc
2c

4.34 b
1.31 b
2.79 bc
20 b
12 a
7b
5 bc

* Values within rows having the same letters are not different (P<0.05)
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Figure 5.1 Viable cells of (A) Enterobacter sakazakii Fec39 and (B) E. sakazakii MSDH in cold Ison seed extract (□), hot Ison
seed extract (), cold Carlos seed extract (∆) and hot Carlos seed extract (▲). Control (*) shows the viable E.
sakazakii in tryptic soy broth.

Viable cell (log CFU/mL)

(A)

Viable cell (log CFU/mL)

Table 5.2 Decimal reduction times (D values) for Enterobacter sakazakii in
muscadine seed extracts
D values (min) for E. sakazakii
Cultivars

Extraction
methods

Ison
Carlos

E. sakazakii
Fec39

E. sakazakii
MSDH

Cold
Hot

45.3
25.0

50.2
41.8

Cold
Hot

93.4
55.9

146.0
70.3

Table 5.3

Pearson correlation analysis performed between the
components in the muscadine seed extracts and
Enterobacter sakazakii log reduction
E. sakazakii log deduction

Components

R2

p

Ellagic acid
Tannic acid
Gallic acid
Malic acid
pH
Tartaric acid

0.878
0.876
0.867
0.861
-0.855
0.838

<0.01
<0.01
<0.01
<0.01
<0.01
<0.01

Catechin

0.804

<0.05

Total phenolics
Epicatechin

0.699
0.634

>0.05
>0.05
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CHAPTER VI
SUMMARY AND CONCLUSIONS

In the agar spot tests, the diluted commercial yogurt containing approximately 106
CFU/mL lactic acid bacteria was antagonistic toward Enterobacter sakazakii. The
average diameters of clear zones produced by pure cultures of Lactobacillus helveticus
CNRZ32, L. bulgaricus LL18, and diluted yogurt were 11.6, 11.8, and 10.3 mm,
respectively. As the concentration of E. sakazakii decreased, the increase in yogurt
antagonistic effect was observed. The average diameters of inhibition zones were
12.8, 10.9, and 8.8 mm when 0.01, 0.1, and 1% of E. sakazakii were applied,
respectively.
After 180 min incubation in the simulated gastric model, about 35% of
Lactobacillus, Streptococcus, and E. sakazakii in yogurt and/or milk remained viable
(5.5-5.9 log CFU/mL reduced). The viable cell numbers decreased rapidly when the
pH in the gastric compartment dropped below 3.0.

All bacterial cells were recovered

after being transferred to the intestinal compartment at various levels.
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Overall,

comparing to yogurt LAB, E. sakazakii was more sensitive to gastric acid with
observed lower D value and the lower survival rate in the simulated gastric
compartment, E. sakazakii, however, recovered better in the intestinal model.

There

was no significant antagonistic effect of yogurt against E. sakazakii at concentration
105 and 108 CFU/mL in the simulated GI model.

The adhesion ability and the

competitive exclusion effect, two important factors of LAB influencing the
antimicrobial effect other than producing antimicrobial compounds, need to be further
determined.
Muscadine juices demonstrated inhibitory effect against E. sakazakii.

Within

two hours, the initial inoculated 106 CFU/mL of E. sakazakii cells were reduced to
non-detectable level in all muscadine juice samples.

Overall, RMJ had lower pH

values, higher contents of tartaric acid, total phenolics and major phenolic acids, and
demonstrated the strongest antimicrobial effect among all tested juice samples.

The

pasteurized muscadine juices were less effective against E. sakazakii than cold sterile
muscadine juices.

When commercial yogurt was added into muscadine juices, 6-log

reduction in viable E. sakazakii was observed within four hours, while there was only
2-log decreasing in viable Lactobacillus for the same duration.
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The characteristics and the antimicrobial effect of the muscadine seed extracts
(seed power: distilled water at 1:5) were also evaluated.

Between the two muscadine

cultivars, seed extracts from ‘Ison’, the dark-skinned muscadine, had lower pH and
higher contents of organic acids, total phenolics, and some major phenolics than the
seed extracts from the light-skinned ‘Carlos’ muscadine. ‘Ison’ seed extracts also
demonstrated stronger inhibitory effects against E. sakazakii.

Hot extraction method

increased the concentrations of organic acids and phenolics in the seed extracts and
enhanced their antimicrobial activity.

The correlation analysis was performed to

predict the relationship between the concentrations of detected components and the
antimicrobial effect of muscadine seed extracts.

The results indicated that the

reduction of E. sakazakii caused by muscadine seed extracts was correlated well to pH
and the concentrations of ellagic, tannic, gallic, malic, and tartaric acids in the seed
extracts.
Results suggested that muscadine juices and seed extracts were strong
antimicrobial agents against E. sakazakii.

Further studies will be necessary for the

application of muscadine products in baby food to help controlling the problem of E.
sakazakii. Although the antimicrobial effect of commercial yogurt was not shown in
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the simulated GI model, the antimicrobial effects observed in the agar spot test and in
the mixture incorporated with muscadine juices were demonstrated. Further works
need to be done in combination with muscadine products or with other probiotic
strains.
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Figure A.1

OD

Growth curve of (A) Enterobacter sakazakii FEC 39 and (B) E. sakazakii
MSDH grow in tryptic soy broth at 37˚C.
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Figure A.2

Standard curve used in Folin-Ciocalteu procedure for total
phenolics determination. The total phenolics were expressed
as milligrams of gallic acid equivalents per milliliter.
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Table A.1

Linear gradient program used for the separation of
phenolic compounds in HPLC analysis

Time (min)
0
1
30
31
32

Table A.2

Solvent A (%)
Methanol/acetic acid/water
95
90
30
90
95

Solvent B (%)
Acetonitrile
5
10
70
10
5

Retention times of organic acids and phenolic
compounds observed in HPLC analysis

Compounds

Retention times (min)

Phenolic compounds at 260 nm
Gallic acid
Catechin
Epicatechin
Ellagic acid
Myricetin
Resveratrol
Quercetin

5.3
7.9
9.2
12.9
15.2
15.8
18.1

Organic acids at 215 nm
Tartaric acid
Malic acid
Tannic acid

4.3
5.2
23.1
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Figure A.3

Standard curve used to quantify tartaric acid in HPLC analysis.
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Figure A.4

Standard curve used to quantify malic acid in HPLC analysis.
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Figure A.6

Standard curve used to quantify gallic acid in HPLC analysis.
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Figure A.7

Standard curve used to quantify catechin in HPLC analysis.
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Figure A.8

Standard curve used to quantify epicatechin in HPLC analysis.
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Figure A.9

Standard curve used to quantify ellagic acid in HPLC analysis.
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Figure A.10

Standard curve used to quantify myricetin in HPLC analysis.
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Figure A.11 Standard curve used to quantify resveratrol in HPLC analysis.
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Figure A.12

Standard curve used to quantify quercetin in HPLC analysis.
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